From: <Salvato da Windows Internet Explorer 7>
Subject: CANCER STEM CELLS: Redefining the Paradigm of Cancer Treatment Strategies -- Dean 6 (3): 140 -- Molecular Interventions
Date: Fri, 25 Jan 2008 18:27:43 +0100
MIME-Version: 1.0
Content-Type: multipart/related;
	type="text/html";
	boundary="----=_NextPart_000_0000_01C85F7F.F9B604C0"
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.3198

This is a multi-part message in MIME format.

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: text/html;
	charset="Windows-1252"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://molinterv.aspetjournals.org/cgi/content/full/6/3/140

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>CANCER STEM CELLS: Redefining the Paradigm of Cancer =
Treatment Strategies -- Dean 6 (3): 140 -- Molecular =
Interventions</TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dwindows-1252">
<SCRIPT language=3DJavaScript>=0A=
	<!--=0A=
	function startTarget(windowname,wid,hei) {=0A=
	=0A=
	var dotpos =3D windowname.indexOf(".");=0A=
	if (dotpos > -1)=0A=
	{=0A=
	var tempwn =3D windowname.substring(0,dotpos) +=0A=
		windowname.substring(dotpos + 1, windowname.length);=0A=
	windowname =3D tempwn;=0A=
	}=0A=
	var sizestring =3D 'width=3D' + wid + ',height=3D' + hei;=0A=
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');=0A=
	}=0A=
	// -->=0A=
	</SCRIPT>
<!-- has inhead tag -->
<SCRIPT language=3DJavaScript>=0A=
	<!--=0A=
	if ( top !=3D self )=0A=
	{=0A=
		top.location.href =3D unescape(window.location.pathname);=0A=
	}=0A=
	//-->=0A=
	</SCRIPT>

<STYLE type=3Dtext/css>TABLE.content_box_outer_table {
	PADDING-RIGHT: 0px; PADDING-LEFT: 10px; PADDING-BOTTOM: 5px; =
PADDING-TOP: 0px
}
TABLE.content_box_outer_table_in_sidebar_frame {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 10px
}
TABLE.content_box_inner_table {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 65%; PADDING-BOTTOM: =
5px; PADDING-TOP: 0px; FONT-FAMILY: Verdana,Arial,Helvetica,sans-serif; =
BACKGROUND-COLOR: #f0f0f0
}
TABLE.content_box_pdfinframes {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 4px; =
PADDING-TOP: 0px
}
TD.content_box_title_highlight {
	PADDING-RIGHT: 1px; PADDING-LEFT: 1px; FONT-WEIGHT: bold; FONT-SIZE: =
120%; PADDING-BOTTOM: 1px; VERTICAL-ALIGN: middle; COLOR: #ffffff; =
PADDING-TOP: 1px; FONT-STYLE: italic; FONT-FAMILY: "Trebuchet =
MS",Verdana,Arial,Helvetica,sans-serif; BACKGROUND-COLOR: #003399; =
TEXT-ALIGN: center
}
TD.content_box_title {
	PADDING-RIGHT: 1px; PADDING-LEFT: 1px; FONT-WEIGHT: bold; FONT-SIZE: =
120%; PADDING-BOTTOM: 1px; VERTICAL-ALIGN: middle; COLOR: #ffffff; =
PADDING-TOP: 1px; FONT-STYLE: italic; FONT-FAMILY: "Trebuchet =
MS",Verdana,Arial,Helvetica,sans-serif; BACKGROUND-COLOR: #828282; =
TEXT-ALIGN: center
}
TD.content_box_space_between_sections {
	PADDING-TOP: 2px
}
TD.content_box_arrow {
	PADDING-RIGHT: 0px; PADDING-LEFT: 5px; PADDING-BOTTOM: 3px; =
PADDING-TOP: 0px; TEXT-ALIGN: right
}
TD.content_box_item {
	PADDING-RIGHT: 5px; PADDING-LEFT: 3px; PADDING-BOTTOM: 3px; =
VERTICAL-ALIGN: top; PADDING-TOP: 0px; TEXT-ALIGN: left
}
TD.content_box_pdfinframes_citation_cell {
	BORDER-RIGHT: #000000 1px solid; PADDING-RIGHT: 3px; BORDER-TOP: =
#000000 1px solid; PADDING-LEFT: 3px; FONT-SIZE: 65%; PADDING-BOTTOM: =
3px; BORDER-LEFT: #000000 1px solid; PADDING-TOP: 3px; BORDER-BOTTOM: =
#000000 1px solid; FONT-FAMILY: Verdana,Arial,Helvetica,sans-serif; =
BACKGROUND-COLOR: #ffffff; TEXT-ALIGN: left
}
FONT.openaccess {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-WEIGHT: bold; =
BACKGROUND-COLOR: #ffffff
}
FONT.openaccess_open {
	COLOR: #000000
}
FONT.openaccess_access {
	COLOR: #cc0000
}
FONT.openaccess_oa {
=09
}
.content_box_openaccess_title {
	WHITE-SPACE: nowrap; BACKGROUND-COLOR: #bababa; TEXT-ALIGN: center
}
DIV.referrer-based-search-line {
	PADDING-RIGHT: 25px; PADDING-LEFT: 25px; FONT-SIZE: 0.75em; =
PADDING-BOTTOM: 3px; MARGIN: 0px 4px 5px 0px; PADDING-TOP: 3px; =
FONT-FAMILY: arial,sans-serif; BACKGROUND-COLOR: #009918
}
DIV.referrer-based-search-line .search-terms {
	FONT-WEIGHT: bold
}
DIV.referrer-based-search-line .collection-name {
	FONT-STYLE: italic
}

@media Print, Screen, Handheld   =20
{
.notonscreen {
	DISPLAY: none
}

}
</STYLE>

<STYLE type=3Dtext/css>
@media Print, Screen, Handheld   =20
{
.notonscreen {
	DISPLAY: none
}

}
</STYLE>
<!-- ac in the head available -->
<SCRIPT language=3Djavascript>=0A=
		<!-- =0A=
	function popwin(url,wid,hei,fromtop,fromleft) {=0A=
		var winPref =3D =
"channelmode=3Dno,toolbar=3Dno,location=3Dno,directories=3Dno,status=3Dno=
,menubar=3Dno,scrollbars=3Dauto,resizable=3Dno,width=3D" + wid + =
",height=3D" + hei + ",top=3D" + fromtop + ",left=3D" + fromleft;=0A=
		window.open(url, "popwin", winPref);=0A=
	}=0A=
	// -->=0A=
	</SCRIPT>

<SCRIPT=20
src=3D"http://molinterv.aspetjournals.org/javascript/ajax/xmlhttprequest.=
js"=20
type=3Dtext/javascript></SCRIPT>

<SCRIPT =
src=3D"http://molinterv.aspetjournals.org/javascript/ajax/utility.js"=20
type=3Dtext/javascript></SCRIPT>

<SCRIPT =
src=3D"http://molinterv.aspetjournals.org/javascript/entrez/callback.js" =

type=3Dtext/javascript></SCRIPT>

<META content=3Dnofollow name=3Drobots>
<META content=3D"Molecular Interventions" name=3Dcitation_journal_title>
<META content=3D"Dean, Michael" name=3Dcitation_authors>
<META=20
content=3D"CANCER STEM CELLS: Redefining the Paradigm of Cancer =
Treatment Strategies"=20
name=3Dcitation_title>
<META content=3D06/01/2006 name=3Dcitation_date>
<META content=3D6 name=3Dcitation_volume>
<META content=3D3 name=3Dcitation_issue>
<META content=3D140 name=3Dcitation_firstpage>
<META content=3D10.1124/mi.6.3.5 name=3Dcitation_doi>
<META =
content=3Dhttp://molinterv.aspetjournals.org/cgi/reprint/6/3/140.pdf=20
name=3Dcitation_pdf_url>
<META =
content=3Dhttp://molinterv.aspetjournals.org/cgi/content/abstract/6/3/140=
=20
name=3Dcitation_abstract_html_url>
<META =
content=3Dhttp://molinterv.aspetjournals.org/cgi/content/full/6/3/140=20
name=3Dcitation_fulltext_html_url>
<META content=3D16809475 name=3Dcitation_pmid>
<META content=3D"Dean, Michael" name=3Ddc.Contributor>
<META=20
content=3D"CANCER STEM CELLS: Redefining the Paradigm of Cancer =
Treatment Strategies"=20
name=3Ddc.Title>
<META content=3D10.1124/mi.6.3.5 name=3Ddc.Identifier>
<META content=3D06/01/2006 name=3Ddc.Date>
<META content=3DASPET name=3Dcitation_publisher>
<META content=3DNOARCHIVE name=3DROBOTS>
<META content=3D"MSHTML 6.00.6000.16587" name=3DGENERATOR></HEAD>
<BODY bgColor=3D#ffffff><A name=3Dtop><!-- null --></A>
<TABLE cellSpacing=3D0 cellPadding=3D0 border=3D0>
  <TBODY>
  <TR>
    <TD vAlign=3Dbottom noWrap><A style=3D"TEXT-DECORATION: none"=20
      href=3D"http://molinterv.aspetjournals.org/" target=3D_top><IMG =
height=3D44=20
      alt=3DMI =
src=3D"http://molinterv.aspetjournals.org/icons/banner/title.gif"=20
      width=3D220 border=3D0></A> <A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/adclick/?ad=3D848&amp;adcl=
ick=3Dtrue&amp;url=3Dhttp%3A%2F%2Fwww.aspet.org%2F"><IMG=20
      height=3D40 alt=3D"Visit the ASPET Website"=20
      =
src=3D"http://molinterv.aspetjournals.org/adsystem/graphics/1201282056287=
/molint/990125570.gif?ad=3D848&amp;adview=3Dtrue"=20
      width=3D220 border=3D1></A>=20
      <TABLE cellSpacing=3D2 cellPadding=3D2 width=3D450>
        <TBODY>
        <TR>
          <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
            style=3D"TEXT-DECORATION: none"=20
            href=3D"http://molinterv.aspetjournals.org/" =
target=3D_top><FONT=20
            face=3Darial,helvetica color=3D#ffffff =
size=3D-2>HOME</FONT></A></TD>
          <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
            style=3D"TEXT-DECORATION: none"=20
            href=3D"http://molinterv.aspetjournals.org/help/" =
target=3D_top><FONT=20
            face=3Darial,helvetica color=3D#ffffff =
size=3D-2>HELP</FONT></A></TD>
          <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
            style=3D"TEXT-DECORATION: none"=20
            href=3D"http://molinterv.aspetjournals.org/cgi/feedback"=20
            target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff=20
            size=3D-2>FEEDBACK</FONT></A></TD>
          <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
            style=3D"TEXT-DECORATION: none"=20
            href=3D"http://molinterv.aspetjournals.org/subscriptions/"=20
            target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff=20
            size=3D-2>SUBSCRIPTIONS</FONT></A></TD>
          <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
            style=3D"TEXT-DECORATION: none"=20
            =
href=3D"http://molinterv.aspetjournals.org/contents-by-date.0.shtml"=20
            target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff=20
            size=3D-2>ARCHIVE</FONT></A></TD>
          <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
            style=3D"TEXT-DECORATION: none"=20
            href=3D"http://molinterv.aspetjournals.org/search.dtl"=20
            target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff=20
            size=3D-2>SEARCH</FONT></A></TD>
          <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
            style=3D"TEXT-DECORATION: none"=20
            =
href=3D"http://molinterv.aspetjournals.org/content/vol6/issue3/"=20
            target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>TABLE=20
            OF CONTENTS</FONT></A></TD></TR></TBODY></TABLE></TD>
    <TD><IMG height=3D5 alt=3D" "=20
      src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif" =
width=3D5></TD>
    <TD vAlign=3Dbottom>
      <TABLE cellSpacing=3D1 cellPadding=3D0 bgColor=3D#000000 =
border=3D0>
        <TBODY>
        <TR>
          <FORM name=3Dsearch action=3D/cgi/search method=3Dget><INPUT =
type=3Dhidden=20
          value=3Dand name=3Dandorexactfulltext><INPUT type=3Dhidden =
value=3D1=20
          name=3Dresourcetype><INPUT type=3Dhidden =
name=3Ddisp_type><INPUT type=3Dhidden=20
          value=3Drelevance name=3Dsortspec>
          <TD vAlign=3Dcenter align=3Dmiddle>
            <TABLE cellSpacing=3D0 cellPadding=3D1 bgColor=3D#dbdbdb =
border=3D0>
              <TBODY>
              <TR>
                <TD bgColor=3D#003399><IMG height=3D2 alt=3D" "=20
                  =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
                  width=3D2></TD>
                <TD vAlign=3Dcenter noWrap =
bgColor=3D#003399><STRONG><FONT=20
                  face=3Dverdana,arial,helvetica,sans-serif =
color=3D#ffffff=20
                  size=3D-2><EM>QUICK</EM> =
SEARCH:&nbsp;</FONT></STRONG></TD>
                <TD vAlign=3Dcenter noWrap align=3Dright =
bgColor=3D#003399><A=20
                  style=3D"COLOR: #ffffff; TEXT-DECORATION: none"=20
                  =
href=3D"http://molinterv.aspetjournals.org/search.dtl"><FONT=20
                  face=3Dverdana,arial,helvetica color=3D#ffffff=20
                  size=3D-2>&nbsp;[advanced]</FONT></A></TD>
                <TD bgColor=3D#003399><IMG height=3D2 alt=3D" "=20
                  =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
                  width=3D2></TD></TR>
              <TR>
                <TD bgColor=3D#dbdbdb><IMG height=3D2 alt=3D" "=20
                  =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
                  width=3D2></TD>
                <TD bgColor=3D#dbdbdb colSpan=3D2>
                  <TABLE cellSpacing=3D0 cellPadding=3D0 border=3D0>
                    <TBODY>
                    <TR>
                      <TD vAlign=3Dbottom align=3Dmiddle><INPUT =
style=3D"FONT-WEIGHT: bold; FONT-SIZE: 10px; BACKGROUND: #ffffff; COLOR: =
#000000; FONT-FAMILY: verdana,arial,helvetica; TEXT-DECORATION: none" =
type=3Dsubmit value=3DGo></TD>
                      <TH align=3Dleft colSpan=3D2><FONT=20
                        face=3Dverdana,arial,helvetica,sans-serif =
color=3D#000000=20
                        size=3D-2><LABEL=20
                        =
for=3Dqsintdefsauthor1>Author:</LABEL><BR></FONT><INPUT=20
                        id=3Dqsintdefsauthor1=20
                        style=3D"FONT-SIZE: 10px; FONT-FAMILY: =
verdana,arial,helvetica"=20
                        maxLength=3D80 size=3D9 name=3Dauthor1></TH>
                      <TH align=3Dleft colSpan=3D3><FONT=20
                        face=3Dverdana,arial,helvetica,sans-serif =
color=3D#000000=20
                        size=3D-2><LABEL=20
                        =
for=3Dqsintdefsfulltext>Keyword(s):</LABEL><BR></FONT><INPUT=20
                        id=3Dqsintdefsfulltext=20
                        style=3D"FONT-SIZE: 10px; FONT-FAMILY: =
verdana,arial,helvetica"=20
                        maxLength=3D80 size=3D16 =
name=3Dfulltext></TH></TR>
                    <TR>
                      <TH><FONT =
face=3Dverdana,arial,helvetica,sans-serif=20
                        color=3D#000000 size=3D-2><LABEL=20
                        =
for=3Dqsintdefspubdate_year>Year:</LABEL>&nbsp;</FONT></TH>
                      <TD><INPUT id=3Dqsintdefspubdate_year=20
                        style=3D"FONT-SIZE: 10px; FONT-FAMILY: =
verdana,arial,helvetica"=20
                        maxLength=3D4 size=3D4 name=3Dpubdate_year></TD>
                      <TH align=3Dright><FONT=20
                        face=3Dverdana,arial,helvetica,sans-serif =
color=3D#000000=20
                        size=3D-2><LABEL=20
                        =
for=3Dqsintdefsvolume>Vol:</LABEL>&nbsp;</FONT></TH>
                      <TD><INPUT id=3Dqsintdefsvolume=20
                        style=3D"FONT-SIZE: 10px; FONT-FAMILY: =
verdana,arial,helvetica"=20
                        maxLength=3D10 size=3D4 name=3Dvolume></TD>
                      <TH><FONT =
face=3Dverdana,arial,helvetica,sans-serif=20
                        color=3D#000000 size=3D-2><LABEL=20
                        =
for=3Dqsintdefsfirstpage>Page:</LABEL>&nbsp;</FONT></TH>
                      <TD><INPUT id=3Dqsintdefsfirstpage=20
                        style=3D"FONT-SIZE: 10px; FONT-FAMILY: =
verdana,arial,helvetica"=20
                        maxLength=3D10 size=3D4=20
                name=3Dfirstpage></TD></TR></TBODY></TABLE></TD>
                <TD bgColor=3D#dbdbdb><IMG height=3D2 alt=3D" "=20
                  =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
                  =
width=3D2></TD></TR></TBODY></TABLE></TD></FORM></TR></TBODY></TABLE></TD=
></TR>
  <TR>
    <TD colSpan=3D3><IMG height=3D2 alt=3D" "=20
      src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif" =
width=3D2><BR><!-- subline logic: standard default --><!-- NOT GUEST -->
      <HR align=3Dleft color=3D#000000 noShade SIZE=3D1>
    </TD></TR></TBODY></TABLE><FONT size=3D-1><EM>Molecular =
Interventions</EM>=20
6:140-148, (2006)</FONT><BR>=A9 <A=20
href=3D"http://molinterv.aspetjournals.org/misc/terms.shtml">American =
Society for=20
Pharmacology and Experimental =
Therapeutics</A><BR>10.1124/mi.6.3.5<BR></FONT>
<TABLE class=3Dcontent_box_outer_table align=3Dright>
  <TBODY>
  <TR>
    <TD><!-- beginning of inner table -->
      <TABLE class=3Dcontent_box_inner_table><!-- citation -->
        <TBODY>
        <TR>
          <TD class=3Dcontent_box_title_highlight colSpan=3D2>This =
Article</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content/abstract/6/3/140">=
Summary</A></STRONG>=20
            <IMG height=3D7 alt=3D"Freely available"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/toc/free.gif"=20
            width=3D32 border=3D0> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/reprint/6/3/140"><STRONG>F=
ull=20
            Text</STRONG> (PDF)</A> </STRONG></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/alerts/ctalert?alertType=3D=
citedby&amp;addAlert=3Dcited_by&amp;saveAlert=3Dno&amp;cited_by_criteria_=
resid=3Dmolint;6/3/140&amp;return_type=3Darticle&amp;return_url=3Dhttp%3A=
%2F%2Fmolinterv.aspetjournals.org%2Fcgi%2Fcontent%2Ffull%2F6%2F3%2F140">A=
lert=20
            me when this article is cited</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/alerts/ctalert?alertType=3D=
correction&amp;addAlert=3Dcorrection&amp;saveAlert=3Dno&amp;correction_cr=
iteria_value=3D6/3/140&amp;return_type=3Darticle&amp;return_url=3Dhttp%3A=
%2F%2Fmolinterv.aspetjournals.org%2Fcgi%2Fcontent%2Ffull%2F6%2F3%2F140">A=
lert=20
            me if a correction is posted</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>Services</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/search?qbe=3Dmolint;6/3/14=
0&amp;journalcode=3Dmolint&amp;minscore=3D5000">Similar=20
            articles in this journal</A> </STRONG></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
16809475&amp;link_type=3DMED_NBRS">Similar=20
            articles in PubMed</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/alerts/etoc">Alert me=20
            to new issues of the journal</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/citmgr?gca=3Dmolint;6/3/14=
0">Download=20
            to citation manager</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>Citing =
Articles</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
http://molinterv.aspetjournals.org/cgi/content/abstract/6/3/140&amp;link_=
type=3DGOOGLESCHOLAR"=20
            target=3D_blank>Citing Articles via Google =
Scholar</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>Google =
Scholar</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://scholar.google.com/scholar?q=3D%22author%3AM.+author%3ADea=
n%22"=20
            target=3D_blank>Articles by Dean, M.</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
http://molinterv.aspetjournals.org/cgi/content/abstract/6/3/140&amp;link_=
type=3DGOOGLESCHOLARRELATED"=20
            target=3D_blank>Search for Related Content</A></STRONG> =
</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>PubMed</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
16809475&amp;link_type=3DPUBMED">PubMed=20
            Citation</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
Dean+M&amp;link_type=3DAUTHORSEARCH"=20
            target=3D_blank>Articles by Dean, M.</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG=20
            class=3Dcontent_box_inner_title>Pubmed/NCBI =
databases</STRONG>
            <TABLE class=3Dcontent_box_inner_table style=3D"FONT-SIZE: =
100%"=20
            summary=3D"Entrez Links for this Article">
              <TBODY style=3D"FONT-SIZE: 100%">
              <TR style=3D"FONT-SIZE: 100%">
                <TH style=3D"FONT-SIZE: 100%; TEXT-ALIGN: left"=20
                  colSpan=3D2>Medline Plus Health Information</TH></TR>
              <TR style=3D"FONT-SIZE: 100%">
                <TD style=3D"FONT-SIZE: 100%; WHITE-SPACE: nowrap"=20
                  colSpan=3D2><IMG class=3Ddot height=3D9 alt=3D*=20
                  =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/dot.gif"=20
                  width=3D8><A=20
                  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?id=3DMEDPLUS&=
amp;target=3Dhttp%3A%2F%2Fwww.nlm.nih.gov%2Fmedlineplus%2Fcancer.html&amp=
;type=3Dllinks&amp;pmid=3D16809475&amp;link_type=3DENTREZLINKS"=20
                  target=3D_blank>Cancer</A></TD></TR>
              <TR style=3D"FONT-SIZE: 100%">
                <TD style=3D"FONT-SIZE: 100%; WHITE-SPACE: nowrap"=20
                  colSpan=3D2><IMG class=3Ddot height=3D9 alt=3D*=20
                  =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/dot.gif"=20
                  width=3D8><A=20
                  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?id=3DMEDPLUS&=
amp;target=3Dhttp%3A%2F%2Fwww.nlm.nih.gov%2Fmedlineplus%2Fstemcells.html&=
amp;type=3Dllinks&amp;pmid=3D16809475&amp;link_type=3DENTREZLINKS"=20
                  target=3D_blank>Stem=20
        =
Cells</A></TD></TR></TBODY></TABLE></TD></TR></TD></TR></TBODY></TABLE></=
TD></TR></TBODY></TABLE><FONT=20
size=3D+1>Review</FONT>=20
<H2>CANCER STEM CELLS: Redefining the Paradigm of Cancer Treatment =
Strategies=20
</H2><STRONG></NOBR><NOBR>Michael Dean<SUP></SUP></NOBR> </STRONG>
<P><FONT size=3D-1>National Cancer Institute=96Frederick Cancer Research =
and=20
Development Center, Bldg 560, Frederick, MD 21702 </FONT>
<P><SUP></SUP><BR clear=3Dright>
<P align=3Dcenter><IMG height=3D352 alt=3D"Formula "=20
src=3D"http://molinterv.aspetjournals.org/content/vol6/issue3/images/medi=
um/TitleArt_Dean.gif"=20
width=3D440 border=3D0></P>
<P><A name=3DABS><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp; S<FONT=20
      size=3D-1>UMMARY</FONT> </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#top">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>TOP<BR></A><IMG height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT color=3D#464c53>Summary</FONT><BR><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC1"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>The Cancer Stem Cell...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC2"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Normal and Abnormal Stem...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC3"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Stem Cell Activation and...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC4"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Research Implications<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC5"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Treatment Implications<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC6"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Conclusions<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#BIBL"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      =
border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>C=
ancer has=20
been known to arise from long-lived cells in the<SUP> </SUP>body and to =
possess=20
properties in common with undifferentiated,<SUP> </SUP>embryonic cells. =
Recent=20
findings of a population of cells in<SUP> </SUP>solid tumors resembling =
stem=20
cells supports a stem cell model<SUP> </SUP>of cancer. A scheme in which =
all=20
cancers initiate from "activated"<SUP> </SUP>stem cells helps bring =
together=20
data from genetic, cell biology,<SUP> </SUP>and epidemiology studies. =
Cancer can=20
arise from embryonic cells<SUP> </SUP>in the case of childhood tumors;=20
hormone-activated stem cells<SUP> </SUP>in the case of breast cancer; =
and=20
following chronic activation<SUP> </SUP>of stem cells caused by tissue =
damage.=20
This scheme helps explain<SUP> </SUP>the failure of many cancer =
therapies,=20
points out deficiencies<SUP> </SUP>in certain research approaches, and =
focuses=20
the problem on a<SUP> </SUP>subset of cells that can be explicitly =
targeted,=20
leading to<SUP> </SUP>more efficient therapy.<SUP> </SUP>
<P><A name=3DSEC1><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp; T<FONT=20
      size=3D-2>HE</FONT> C<FONT size=3D-2>ANCER</FONT> S<FONT =
size=3D-2>TEM</FONT>=20
      C<FONT size=3D-2>ELL</FONT> C<FONT size=3D-2>ONCEPT</FONT>=20
  </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#top">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>TOP<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#ABS">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Summary<BR></A><IMG height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT color=3D#464c53>The Cancer Stem =
Cell...</FONT><BR><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC2"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Normal and Abnormal Stem...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC3"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Stem Cell Activation and...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC4"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Research Implications<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC5"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Treatment Implications<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC6"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Conclusions<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#BIBL"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      =
border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>T=
he idea=20
that cancer cells have properties in common with embryonic<SUP> =
</SUP>cells is=20
an old one. Cancer cells divide rapidly and are immortal,<SUP> </SUP>as =
are=20
embryonic stem cells. Embryonal carcinomas and teratocarcinomas<SUP> =
</SUP>have=20
long fascinated cancer biologists as they are derived from<SUP> =
</SUP>embryonic=20
cells and give rise to cells of many lineages. Beatrice<SUP> </SUP>Mintz =
showed=20
in 1975 that teratocarcinomas could give rise to<SUP> </SUP>normal =
chimeric mice=20
<I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R1">1=
</A>)</I>.=20
Hamburger and Salmon demonstrated<SUP> </SUP>that a subpopulation of =
cells in a=20
tumor will grow in soft agar,<SUP> </SUP>and termed these cells "tumor =
stem=20
cells" <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R2">2=
</A>)</I>.=20
In 1993, Al Knudson<SUP> </SUP>proposed that the ability of many tumor=20
suppressor genes to<SUP> </SUP>give rise to specific cancers could be =
explained=20
by their effects<SUP> </SUP>on tissue stem cells <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R3">3=
</A>)</I>.=20
John Dick proved in 1994 that cancerous<SUP> </SUP>stem cells were =
present in=20
acute myelogenous leukemia by isolating<SUP> </SUP>such cells and =
documenting=20
their self-renewing capacity=97the<SUP> </SUP>critical property of all =
stem cells=20
<I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R4">4=
</A>)</I>.=20
Additionally, alteration<SUP> </SUP>in the growth regulation of stem =
cells has=20
been invoked to explain<SUP> </SUP>the role of the Patched (PTCH) gene =
in=20
causing basal cell carcinomas<SUP> </SUP>in patients with nevoid basal =
cell=20
carcinoma syndrome <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R5">5=
</A>)</I>.<SUP>=20
</SUP>
<P>Thus, the term cancer stem cell has arisen to describe cells<SUP> =
</SUP>that=20
represent a minor population of a tumor and have the property<SUP> =
</SUP>of=20
self-renewal. Self-renewal involves the replication of a<SUP> </SUP>stem =
cell=20
generating, in the simplest example, another stem<SUP> </SUP>cell and a =
cell=20
committed to differentiate. After many cell<SUP> </SUP>divisions, a =
tumor=20
arising from a single stem cell is composed<SUP> </SUP>of cancer stem =
cells and=20
non-stem cells that have a limited<SUP> </SUP>lifespan. Cancer stem =
cells could=20
arise from normal stem cells,<SUP> </SUP>from committed cells that =
acquire the=20
ability self-renewal capability,<SUP> </SUP>or by the fusion of normal =
stem=20
cells with cancer cells.<SUP> </SUP>
<P>It has been the identification of a small population of cancer<SUP>=20
</SUP>stem cells in solid tumors such as breast and brain, however,<SUP> =

</SUP>that has captivated the field <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R6">6=
</A>, <A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R7">7=
</A>)</I>.=20
These stem cells appear<SUP> </SUP>to be the only cells in the tumor =
capable of=20
immortal growth<SUP> </SUP>and transplantation of the tumor. Perhaps =
more=20
astonishing is<SUP> </SUP>the discovery in long established cell lines, =
even=20
HeLa cells,<SUP> </SUP>of a minor population of cells with stem cell =
properties=20
<I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R8">8=
</A>,<SUP>=20
</SUP><A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R9">9=
</A>)</I>.=20
Many researchers now suspect all cancers are composed of<SUP> </SUP>a =
mixture of=20
renewing stem cells and "committed" cells that<SUP> </SUP>continue to=20
proliferate but have a limited life span. The implications<SUP> </SUP>of =
this=20
concept are important for basic science and well as<SUP> </SUP>cancer =
therapy.=20
The regrowth of many cancers following therapy<SUP> </SUP>could =
represent the=20
survival of cancer stem cells, just as the<SUP> </SUP>patient=92s hair =
follicles=20
and hematopoietic cells recover,<SUP> </SUP>because of the survival of=20
hematopoietic and skin stem cells.<SUP> </SUP>A fraction of cells in a =
tumor are=20
known to survive radiation<SUP> </SUP>treatment and cytotoxic drug =
exposure=20
<I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R10">=
10</A>)</I>.=20
Stem cells express<SUP> </SUP>drug transporters, DNA repair systems, and =
are=20
refractory to<SUP> </SUP>programmed cell death, all properties that =
would serve=20
to allow<SUP> </SUP>a cancer cell to resist our efforts to eliminate it =
<I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R11">=
11</A>=96<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R13">=
13</A>)</I>.<SUP>=20
</SUP>
<P><A name=3DSEC2><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp; N<FONT=20
      size=3D-2>ORMAL</FONT><FONT size=3D-1> </FONT><FONT =
size=3D-2>AND</FONT> A<FONT=20
      size=3D-2>BNORMAL</FONT> S<FONT size=3D-2>TEM</FONT> C<FONT=20
      size=3D-2>ELLS</FONT> </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#top">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>TOP<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#ABS">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Summary<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC1"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>The Cancer Stem Cell...<BR></A><IMG height=3D9 alt=3D" =
" hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT color=3D#464c53>Normal and Abnormal =
Stem...</FONT><BR><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC3"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Stem Cell Activation and...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC4"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Research Implications<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC5"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Treatment Implications<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC6"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Conclusions<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#BIBL"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      =
border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>T=
he=20
earliest cells of an embryo are totipotent stem cells, able<SUP> =
</SUP>to give=20
rise to all the cell types of the body. These cells<SUP> =
</SUP>differentiate=20
into more restricted, multipotent stem cells and<SUP> </SUP>then to the =
further=20
restricted tissue stem cells. All stem cells<SUP> </SUP>have the =
property of=20
dividing and giving rise to additional<SUP> </SUP>stem cells as well as =
to cells=20
committed to differentiation<SUP> </SUP>that eventually stop dividing or =
undergo=20
apoptosis <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R14">=
14</A>)</I>.=20
Some<SUP> </SUP>stem cells, such as hematopoietic stem cells, continue=20
relatively<SUP> </SUP>rapid division, to maintain the massive number of=20
lymphocytes<SUP> </SUP>and red blood cells needed by the body. Other =
stem cells,=20
such<SUP> </SUP>as those in the skin and colon, undergo a slow but =
constant<SUP>=20
</SUP>growth, replenishing the tissue, whereas other tissue stem =
cells<SUP>=20
</SUP>can remain quiescent to become activated when stimulated by<SUP>=20
</SUP>tissue damage or hormone exposure. It becomes obvious then =
that<SUP>=20
</SUP>the proliferation of all the different types of stem cells in<SUP> =

</SUP>the adult requires exquisite control and that aberrant =
regulation<SUP>=20
</SUP>could be hazardous. Cancer stem cells can arise from two =
potential<SUP>=20
</SUP>pathways: 1) a stem cell losing growth regulation could =
directly<SUP>=20
</SUP>become a cancer stem cell, or 2) a mature (i.e., =
differentiated<SUP>=20
</SUP>or committed cell) could acquire the properties of self =
renewal<SUP>=20
</SUP>and become a cancer stem cell (Figure 1<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#F1"><=
IMG=20
height=3D7 alt=3DGo =
src=3D"http://molinterv.aspetjournals.org/icons/fig-down.gif"=20
width=3D8 border=3D1></A>). There is good evidence<SUP> </SUP>for both =
mechanisms,=20
as well as the possibility that these two<SUP> </SUP>pathways might be =
utilized=20
in differing proportions at different<SUP> </SUP>times within the tumor. =
In=20
fact, transfection studies in which<SUP> </SUP>human oncogenes transform =
murine=20
fibroblasts demonstrate that<SUP> </SUP>non-stem cells can be converted =
into=20
cancer (stem) cells. An<SUP> </SUP>even more outlandish idea is that =
normal=20
hematopoietic stem<SUP> </SUP>cells may fuse with tissue cells to =
generate=20
cancer stem cells<SUP> </SUP>(i.e., the formation of an in vivo =
hybridoma)=20
<I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R15">=
15</A>)</I>.<SUP>=20
</SUP>
<P><A name=3DF1><!-- null --></A><BR clear=3Dall>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%">
  <TBODY>
  <TR bgColor=3D#e1e1e1>
    <TD>
      <TABLE cellSpacing=3D2 cellPadding=3D2>
        <TBODY>
        <TR bgColor=3D#e1e1e1>
          <TD vAlign=3Dtop align=3Dmiddle bgColor=3D#ffffff><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140/F1"><=
IMG=20
            height=3D95 alt=3D"Figure 1" hspace=3D10=20
            =
src=3D"http://molinterv.aspetjournals.org/content/vol6/issue3/images/smal=
l/Fig1_Dean.gif"=20
            width=3D200 vspace=3D5 border=3D2></A><BR><STRONG>View =
larger=20
            version</STRONG> (11K):<BR><NOBR><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140/F1">[=
in=20
            this window]</A><BR><A=20
            onmouseover=3D"window.status=3D'View figure in a separate =
window'; return true"=20
            onclick=3D"startTarget('F1', 590, 408); =
this.href=3D'/cgi/content-nw/full/6/3/140/F1'"=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content-nw/full/6/3/140/F1=
"=20
            target=3DF1>[in a new window]</A><BR>&nbsp;</NOBR> </TD>
          <TD vAlign=3Dtop align=3Dleft><B>Figure 1.</B> <B>Two stages =
involved in=20
            cancer stem cell activation.</B> Cancer requires the =
generation of=20
            an actively dividing or "activated" stem cell. This cell may =
be an=20
            actively dividing stem cell, a stem cell stimulated to =
divide by=20
            tissue damage or inflammation, or from an a differentiated =
(mature)=20
            cell acquiring the property of self-renewal. Mutations =
inactivating=20
            tumor suppressor genes (negative regulators of growth) or =
activating=20
            oncogenes (positive regulators) convert the activated stem =
cell into=20
            a cancer stem cell. Further mutations are required for tumor =

            progression and metastasis.
            =
<P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>&nbsp=
;<BR><A=20
name=3DSEC3><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp; S<FONT=20
      size=3D-2>TEM</FONT> C<FONT size=3D-2>ELL</FONT> A<FONT=20
      size=3D-2>CTIVATION</FONT><FONT size=3D-1> </FONT><FONT =
size=3D-2>AND</FONT>=20
      C<FONT size=3D-2>ANCER</FONT> </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#top">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>TOP<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#ABS">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Summary<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC1"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>The Cancer Stem Cell...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC2"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Normal and Abnormal Stem...<BR></A><IMG height=3D9 =
alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT color=3D#464c53>Stem Cell Activation =
and...</FONT><BR><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC4"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Research Implications<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC5"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Treatment Implications<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC6"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Conclusions<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#BIBL"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      =
border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>A=
ctivation=20
of a stem cell can happen in three ways. 1) The stem<SUP> </SUP>cell may =
be=20
naturally dividing, as in the embryo or the hematopoietic<SUP> =
</SUP>system; 2)=20
the stem cell can be activated by hormone such as<SUP> </SUP>estrogen =
for breast=20
and ovarian cells; 3) the stem cell may<SUP> </SUP>be stimulated to =
divide=20
through tissue damage caused by inflammation,<SUP> </SUP>chemical =
exposure or=20
infection. With regard to cancer stem cells,<SUP> </SUP>it becomes of =
central=20
importance for researchers to understand<SUP> </SUP>how stem cells take =
this=20
first activation step. A model of stem<SUP> </SUP>cell activation and =
cancer=20
should take into account the many<SUP> </SUP>diverse types of cancer and =
their=20
varied causes. Such a model<SUP> </SUP>in which stem cell "activation" =
is the=20
key first step satisfies<SUP> </SUP>many observations (Figure 1<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#F1"><=
IMG=20
height=3D7 alt=3DGo =
src=3D"http://molinterv.aspetjournals.org/icons/fig-up.gif"=20
width=3D8 border=3D1></A>). Activation could occur through<SUP> =
</SUP>hormonal=20
stimulation; tissue damage caused by inflammation,<SUP> </SUP>radiation, =

chemicals, or infections; or inactivation of certain<SUP> </SUP>tumor =
suppressor=20
genes (Table 1<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#T1"><=
IMG=20
height=3D7 alt=3DGo =
src=3D"http://molinterv.aspetjournals.org/icons/fig-down.gif"=20
width=3D8 border=3D1></A>). An activated stem cell would<SUP> </SUP>be a =
target for=20
further genetic events leading to autonomous<SUP> </SUP>growth, loss of =
cell=20
cycle regulation, and resistance to apoptosis=97all<SUP> </SUP>well =
understood=20
properties of cancer cells <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R16">=
16</A>)</I>.=20
This model<SUP> </SUP>accounts for experimental observations on tumor =
initiators=20
and<SUP> </SUP>promoters <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R17">=
17</A>)</I>.=20
Most of the environmental agents causing stem-cell<SUP> </SUP>activation =
would=20
be classified as promoters, non-DNA-reactive<SUP> </SUP>agents that =
enhance the=20
tumorigenicity of initiators (i.e.,<SUP> </SUP>mutagens). Some =
environmental=20
agents, such as tobacco smoke<SUP> </SUP>and UV irradiation, contribute =
to both=20
initiation and promotion<SUP> </SUP>by stimulating tissue proliferation =
and=20
damaging DNA.<SUP> </SUP>
<P><A name=3DT1><!-- null --></A><BR clear=3Dall>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%">
  <TBODY>
  <TR bgColor=3D#e1e1e1>
    <TD>
      <TABLE cellSpacing=3D2 cellPadding=3D2>
        <TBODY>
        <TR bgColor=3D#e1e1e1>
          <TD vAlign=3Dtop align=3Dmiddle bgColor=3D#ffffff><STRONG>View =
this=20
            table:</STRONG><BR><NOBR><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140/T1">[=
in=20
            this window]</A><BR><A=20
            onmouseover=3D"window.status=3D'View table in a separate =
window'; return true"=20
            onclick=3D"startTarget('T1', 500, 400); =
this.href=3D'/cgi/content-nw/full/6/3/140/T1'"=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content-nw/full/6/3/140/T1=
"=20
            target=3DT1>[in a new window]</A><BR>&nbsp;</NOBR> </TD>
          <TD vAlign=3Dtop align=3Dleft><B>Table 1.</B> <B>Routes to =
Stem Cell=20
            Activation</B>=20
</TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>&nbsp;<BR>Ca=
ncers=20
have been proposed to derive from one of three distinct<SUP> =
</SUP>tissue types:=20
embryonic, conditional growth, or renewal <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R3">3=
</A>)</I><SUP>=20
</SUP>(Figure 2<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#F2"><=
IMG=20
height=3D7 alt=3DGo =
src=3D"http://molinterv.aspetjournals.org/icons/fig-down.gif"=20
width=3D8 border=3D1></A>). Embryonic cancers arise from rapidly =
dividing=20
embryonic<SUP> </SUP>stem cells; retinoblastoma is the prototype for =
this type=20
of<SUP> </SUP>cancer <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R18">=
18</A>)</I>.=20
Retinoblastoma arises in retinoblasts, embryonic<SUP> </SUP>cells in the =
eye=20
that are highly proliferative. The target cell<SUP> </SUP>is a naturally =

activated stem cell. The inactivation of the<SUP> </SUP>RB1 gene turns =
this=20
embryonic stem cell into a cancer stem cell<SUP> </SUP>that ignores the =
growth=20
regulatory signals that normally arrest<SUP> </SUP>the stem cell once =
the=20
developing eye is filled with retinoid<SUP> </SUP>cells. Other childhood =
cancers=20
such as Wilm=92s tumor and<SUP> </SUP>leukemias arise from genetic =
events in=20
kidney and hematopoietic<SUP> </SUP>stem cells, respectively. These =
types of=20
cancer require the<SUP> </SUP>fewest genetic events, as the target cell =
is a=20
fully activated<SUP> </SUP>stem cell. Stem cells are also activated by =
hormones=20
and/or<SUP> </SUP>growth factors in conditional growth tissues, as =
described=20
by<SUP> </SUP>Knudson <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R3">3=
</A>)</I>.=20
An example is the breast, which undergoes dramatic<SUP> </SUP>growth =
during=20
puberty and is then stimulated by estrogen and<SUP> </SUP>other hormones =
monthly=20
during the woman=92s reproductive<SUP> </SUP>life <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R19">=
19</A>)</I>.=20
Activated stem cells in the breast would be the target<SUP> </SUP>cell =
for=20
breast cancer. Inactivation of P53 and other genes<SUP> </SUP>would =
transform=20
breast tissue stem cells into hyperplastic lesions,<SUP> </SUP>the =
target for=20
further events leading to the progression of<SUP> </SUP>pre-malignant =
cells to=20
malignancy (Figure 2<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#F2"><=
IMG=20
height=3D7 alt=3DGo =
src=3D"http://molinterv.aspetjournals.org/icons/fig-down.gif"=20
width=3D8 border=3D1></A>).<SUP> </SUP>
<P><A name=3DF2><!-- null --></A><BR clear=3Dall>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%">
  <TBODY>
  <TR bgColor=3D#e1e1e1>
    <TD>
      <TABLE cellSpacing=3D2 cellPadding=3D2>
        <TBODY>
        <TR bgColor=3D#e1e1e1>
          <TD vAlign=3Dtop align=3Dmiddle bgColor=3D#ffffff><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140/F2"><=
IMG=20
            height=3D153 alt=3D"Figure 2" hspace=3D10=20
            =
src=3D"http://molinterv.aspetjournals.org/content/vol6/issue3/images/smal=
l/Fig2_Dean.gif"=20
            width=3D200 vspace=3D5 border=3D2></A><BR><STRONG>View =
larger=20
            version</STRONG> (28K):<BR><NOBR><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140/F2">[=
in=20
            this window]</A><BR><A=20
            onmouseover=3D"window.status=3D'View figure in a separate =
window'; return true"=20
            onclick=3D"startTarget('F2', 590, 536); =
this.href=3D'/cgi/content-nw/full/6/3/140/F2'"=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content-nw/full/6/3/140/F2=
"=20
            target=3DF2>[in a new window]</A><BR>&nbsp;</NOBR> </TD>
          <TD vAlign=3Dtop align=3Dleft><B>Figure 2.</B> <B>Carcinomas =
arising=20
            from activated cancer stem cells in different types of =
tissue.</B>=20
            Embryonic tumors arise from normal embryonic stem cells. =
They are=20
            already rapidly dividing (activated) and require few =
alterations to=20
            become malignant. Conditional growth tissues such as the =
breast are=20
            activated by hormones during puberty and during reproductive =
life.=20
            Activated stem cells in these tissues suffering tumor =
suppressor=20
            gene mutations give rise to premalignant lesions progressing =
to=20
            malignancy. Renewal tissues such as the colon and skin have =
dormant=20
            or slowly replicating stem cells. Certain tumor suppressor =
gene=20
            mutations give rise to activated stem cells with =
uncontrolled=20
            replication. Subsequent mutations give rise to tumor =
progression.
            =
<P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>&nbsp=
;<BR>Breast=20
cancer is one of the best understood tumors; epidemiological<SUP> =
</SUP>risk=20
factors, preventive and therapeutic strategies, and genetic<SUP> =
</SUP>data=20
regarding this disease can be combined into a single scheme<SUP> =
</SUP>(Figure=20
3<A =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#F3"><=
IMG=20
height=3D7 alt=3DGo =
src=3D"http://molinterv.aspetjournals.org/icons/fig-down.gif"=20
width=3D8 border=3D1></A>). The major breast cancer risk factors involve =

hormonal<SUP> </SUP>and reproductive events <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R20">=
20</A>)</I>.=20
Early onset of menarche increases<SUP> </SUP>cancer risk, whereas =
pregnancies=20
decrease risk. Each of these<SUP> </SUP>factors influences either the =
number or=20
activation of breast<SUP> </SUP>stem cells. The major prevention =
strategies=20
currently available<SUP> </SUP>similarly affect either estrogen =
production or=20
its action on<SUP> </SUP>cells. Inhibition of estrogen receptor =
expression=20
activation<SUP> </SUP>or of estrogen production can prevent breast =
cancer in=20
women<SUP> </SUP>at high risk. Similarly, oophorectomy also reduces =
cancer=20
risk<SUP> </SUP><I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R21">=
21</A>).=20
BRCA1</I> and <I>BRCA2</I> mutations are thought to reduce the =
capacity<SUP>=20
</SUP>for DNA repair and therefore raise the risk of breast cancer,<SUP> =

</SUP>by increasing the probability of downstream genetic events =
associated<SUP>=20
</SUP>with tumor progression. Because <I>BRCA1</I> and <I>BRCA2</I> are =
not in=20
the<SUP> </SUP>main (i.e., estrogen dependent) pathway to tumorigenesis, =

they<SUP> </SUP>are not frequently mutated in sporadic tumors.<SUP> =
</SUP>
<P><A name=3DF3><!-- null --></A><BR clear=3Dall>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%">
  <TBODY>
  <TR bgColor=3D#e1e1e1>
    <TD>
      <TABLE cellSpacing=3D2 cellPadding=3D2>
        <TBODY>
        <TR bgColor=3D#e1e1e1>
          <TD vAlign=3Dtop align=3Dmiddle bgColor=3D#ffffff><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140/F3"><=
IMG=20
            height=3D88 alt=3D"Figure 3" hspace=3D10=20
            =
src=3D"http://molinterv.aspetjournals.org/content/vol6/issue3/images/smal=
l/Fig3_Dean.gif"=20
            width=3D200 vspace=3D5 border=3D2></A><BR><STRONG>View =
larger=20
            version</STRONG> (15K):<BR><NOBR><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140/F3">[=
in=20
            this window]</A><BR><A=20
            onmouseover=3D"window.status=3D'View figure in a separate =
window'; return true"=20
            onclick=3D"startTarget('F3', 590, 394); =
this.href=3D'/cgi/content-nw/full/6/3/140/F3'"=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content-nw/full/6/3/140/F3=
"=20
            target=3DF3>[in a new window]</A><BR>&nbsp;</NOBR> </TD>
          <TD vAlign=3Dtop align=3Dleft><B>Figure 3.</B> <B>A =
comprehensive model=20
            for breast cancer.</B> Applying a stem cell model to breast =
cancer=20
            helps explain much of the known data. The major risk factors =
are=20
            hormonal and can act to influence the number and activation =
of stem=20
            cells. Useful prevention strategies inhibit estrogen =
production or=20
            action. <I>BRCA1</I> and <I>BRCA2</I> germline mutations =
increase=20
            the likelihood of <I>P53</I> inactivation (directly or =
through=20
            inhibition of DNA repair), but the BRCA genes are outside of =
the=20
            main pathway and thus are not found in most sporadic tumors.
            =
<P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>&nbsp=
;<BR>For=20
renewal tissues such as the colon or skin, the stem cells<SUP> =
</SUP>divide at a=20
very slow rate. In the absence of perturbation of<SUP> </SUP>these =
tissues,=20
cancer risk is very low. Activation of stem cells<SUP> </SUP>in renewal =
tissues=20
can occur by inflammation, or tissue damage<SUP> </SUP>caused by =
radiation,=20
mutagens, and irritants (Figure 2<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#F2"><=
IMG=20
height=3D7 alt=3DGo =
src=3D"http://molinterv.aspetjournals.org/icons/fig-up.gif"=20
width=3D8 border=3D1></A>). This<SUP> </SUP>chronic tissue damage leads =
to an=20
accelerated division of stem<SUP> </SUP>cells, increasing the available =
number=20
of target cells. In the<SUP> </SUP>colon, inflammatory diseases such as =
Crohn=20
Disease and inflammatory<SUP> </SUP>bowel disease are risk factors for =
cancer,=20
as are high fat/low<SUP> </SUP>fiber diets <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R22">=
22</A>)</I>.=20
Patients with the familial adenomatous polyposis<SUP> </SUP>coli (FAP) =
syndrome=20
have large numbers of colon polyps. Because<SUP> </SUP>polyps are =
pre-malignant=20
lesions, individuals that have polyps<SUP> </SUP>are at very high risk =
for colon=20
cancer <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R23">=
23</A>)</I>.=20
Mutations in <I>APC</I><SUP> </SUP>are responsible for FAP <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R24">=
24</A>,=20
<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R25">=
25</A>)</I>=20
and these patients as well<SUP> </SUP>as mice with an equivalent genetic =

mutation exhibit increased<SUP> </SUP>cellular proliferation in the =
colon <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R26">=
26</A>=96<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R28">=
28</A>)</I>.=20
The effect<SUP> </SUP>of <I>APC</I> mutations might be to increase the=20
proliferation of colonic<SUP> </SUP>stem cells <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R3">3=
</A>)</I>.=20
Consistent with this model, <I>APC</I> is mutated in<SUP> </SUP>the vast =

majority of sporadic colon tumors <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R29">=
29</A>)</I>.=20
The later stage<SUP> </SUP>events in colon carcinogenesis are well known =
and=20
involve mutations<SUP> </SUP>in <I>P53, RAS</I>, and other genes <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R29">=
29</A>)</I>.<SUP>=20
</SUP>
<P>The major environmental risk factors can be classified by their<SUP>=20
</SUP>role in either activating stem cells or contributing to the<SUP>=20
</SUP>formation of a pre-malignant lesion (Table 2<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#T2"><=
IMG=20
height=3D7 alt=3DGo =
src=3D"http://molinterv.aspetjournals.org/icons/fig-down.gif"=20
width=3D8 border=3D1></A>). Many cancers<SUP> </SUP>in solid tissues are =
associated=20
with agents causing inflammation<SUP> </SUP>or irritation of the cells =
in the=20
tissue. Hepatitis B and C<SUP> </SUP>viruses are the principal risk =
factor for=20
liver cancer, one<SUP> </SUP>of the most common cancers in the world =
<I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R30">=
30</A>,=20
<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R31">=
31</A>)</I>.=20
There is no<SUP> </SUP>evidence that HBV or HCV contain genes that =
directly=20
inactivate<SUP> </SUP>tumor suppressor genes; however, patients =
persistently=20
infected<SUP> </SUP>with these viruses usually suffer from liver =
inflammation=20
and<SUP> </SUP>extensive cirrhosis. The liver is known to be =
particularly=20
adept<SUP> </SUP>at regeneration and repairing damaged tissue. Thus,=20
persistent<SUP> </SUP>infection leads to chronic inflammation and tissue =
damage=20
and<SUP> </SUP>continual stimulation of hepatic stem cells.<SUP> </SUP>
<P><A name=3DT2><!-- null --></A><BR clear=3Dall>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%">
  <TBODY>
  <TR bgColor=3D#e1e1e1>
    <TD>
      <TABLE cellSpacing=3D2 cellPadding=3D2>
        <TBODY>
        <TR bgColor=3D#e1e1e1>
          <TD vAlign=3Dtop align=3Dmiddle bgColor=3D#ffffff><STRONG>View =
this=20
            table:</STRONG><BR><NOBR><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140/T2">[=
in=20
            this window]</A><BR><A=20
            onmouseover=3D"window.status=3D'View table in a separate =
window'; return true"=20
            onclick=3D"startTarget('T2', 500, 400); =
this.href=3D'/cgi/content-nw/full/6/3/140/T2'"=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content-nw/full/6/3/140/T2=
"=20
            target=3DT2>[in a new window]</A><BR>&nbsp;</NOBR> </TD>
          <TD vAlign=3Dtop align=3Dleft><B>Table 2.</B> <B>Genetic =
Aberrations=20
            Involved in Cancers Originating from Stem Cells</B>=20
      =
</TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>&nbsp;<BR>As=
bestos=20
is a metabolically inert compound remaining in the<SUP> </SUP>lungs of=20
individuals exposed to large amounts of the fibers.<SUP> </SUP>Asbestos =
exposure=20
causes asbestosis, a fibrotic disease of the<SUP> </SUP>lung. Asbestos =
exposure=20
is also a risk factor for mesothelioma,<SUP> </SUP>a cancer of the =
mesothelial=20
layer of the lung <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R32">=
32</A>)</I>.=20
Asbestos<SUP> </SUP>also works synergistically with tobacco in =
increasing the=20
risk<SUP> </SUP>of other lung cancers <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R33">=
33</A>)</I>.=20
The chronic fibrosis and irritation<SUP> </SUP>caused by asbestos could =
be=20
expected to continuously stimulate<SUP> </SUP>stem cells residing in the =
lung=20
and lead to an increased risk<SUP> </SUP>of mutational events causing =
the=20
formation of a pre-malignant<SUP> </SUP>lesion. Similar rationales can =
be=20
invoked for the association<SUP> </SUP>of infection of the bacterium =
<I>H.=20
pylori</I> and metal dust exposure<SUP> </SUP>with gastric cancer <I>(<A =

href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R34">=
34</A>,=20
<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R35">=
35</A>)</I>=20
and the association of chronic<SUP> </SUP>pancreatitis and diabetes =
mellitus=20
with pancreatic cancer <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R36">=
36</A>)</I>.<SUP>=20
</SUP>
<P>Some agents associated with cancer may contribute both to stem<SUP>=20
</SUP>cell activation as well as downstream mutations and tumor =
suppressor<SUP>=20
</SUP>gene inactivation. Human papilloma viruses, particularly =
HPV16<SUP>=20
</SUP>and 18 are highly associated with cervical cancer <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R37">=
37</A>)</I>.=20
These<SUP> </SUP>viruses contain proteins (i.e., E6 and E7) that inhibit =

the<SUP> </SUP>p53 and RB1 tumor suppressor proteins <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R38">=
38</A>,=20
<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R39">=
39</A>)</I>;=20
however, most<SUP> </SUP>women with pathogenic HPV infection do not =
develop=20
cervical<SUP> </SUP>cancer and so other factors are likely involved. HPV =

infection<SUP> </SUP>of cervical stem cells leads to the increased=20
proliferation<SUP> </SUP>of these cells. Although HPV employs several =
strategies=20
to minimize<SUP> </SUP>the immune response <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R40">=
40</A>)</I>=20
and infected women do not have a visibly<SUP> </SUP>inflamed cervix, the =
immune=20
system does seem to recognize HPV-infected<SUP> </SUP>cells because=20
immunocompromised patients are at increased risk<SUP> </SUP>for cervical =
cancer=20
<I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R41">=
41</A>)</I>.=20
This chronic proliferation provides<SUP> </SUP>an increased pool of =
cells=20
susceptible to viral integration<SUP> </SUP>and disease =
progression.<SUP> </SUP>
<P>The associations of smoking and lung cancer and UV exposure<SUP> =
</SUP>and=20
skin cancer are thought to principally arise from the mutagenic<SUP>=20
</SUP>effects of these agents, and these tissues exhibit highly =
specific<SUP>=20
</SUP>mutations <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R42">=
42</A>)</I>.=20
Tobacco smoke contains several mutagens and<SUP> </SUP>UV irradiation is =
clearly=20
mutagenic. Indeed, both long-term<SUP> </SUP>tobacco use and long-term =
sun=20
exposure are associated with chronic<SUP> </SUP>tissue inflammation and =
damage.=20
These effects are likely to<SUP> </SUP>lead to an increased =
proliferation of=20
tissue stem cells as the<SUP> </SUP>body tries to repair the damaged =
tissue. The=20
constitutively<SUP> </SUP>dividing stem cells in these tissues would be =
targets=20
for carcinogen-induced<SUP> </SUP>mutations, leading to =
tumorigenesis.<SUP>=20
</SUP>
<P><A name=3DSEC4><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp; R<FONT=20
      size=3D-2>ESEARCH</FONT> I<FONT size=3D-2>MPLICATIONS</FONT>=20
  </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#top">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>TOP<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#ABS">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Summary<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC1"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>The Cancer Stem Cell...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC2"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Normal and Abnormal Stem...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC3"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Stem Cell Activation and...<BR></A><IMG height=3D9 =
alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT color=3D#464c53>Research =
Implications</FONT><BR><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC5"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Treatment Implications<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC6"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Conclusions<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#BIBL"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      =
border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>T=
he cancer=20
stem cell concept has profound implications for basic<SUP> </SUP>cancer=20
research. While cancer biologists have long recognized<SUP> </SUP>the=20
heterogeneity of tumor cells, they have assumed that cloned<SUP> =
</SUP>cells=20
lines are homogeneous. We now know this to be untrue,<SUP> </SUP>and the =

analysis of tumor cell cultures involves the study of<SUP> </SUP>a large =

population of committed tumor cells and a small population<SUP> </SUP>of =
tumor=20
stem cells. Thus, gene expression, microarray, proteomic,<SUP> </SUP>and =
many=20
phenotypic assays may need to be reinterpreted. Most<SUP> </SUP>screens =
for=20
cancer cytotoxic drugs have involved cell cultures<SUP> </SUP>treated =
over short=20
time periods <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R43">=
43</A>)</I>.=20
A drug specifically inhibiting<SUP> </SUP>a tumor stem cell may show =
only modest=20
activity in such an assay<SUP> </SUP>and not be chosen for follow up =
study.=20
Clinical studies of stem<SUP> </SUP>cell inhibitors may need to be =
redesigned to=20
capture long term<SUP> </SUP>benefits.<SUP> </SUP>
<P>Through the use of specific cell surface markers tumor stem<SUP> =
</SUP>cells=20
might be isolated from cell lines and characterized. Alternatively<SUP>=20
</SUP>normal stem cells have been purified by taking advantage of<SUP> =
</SUP>the=20
fact that stem cells express transport proteins that efflux<SUP> =
</SUP>certain=20
dyes such as Hoechst and rhodamine. These so called<SUP> =
</SUP>side-population=20
(SP) cells have been found in bone marrow and<SUP> </SUP>normal tissues, =
as well=20
as in tumor cell lines <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R8">8=
</A>, <A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R9">9=
</A>)</I>.=20
The isolation<SUP> </SUP>of such tumor stem cells would likely lead to =
improved=20
understanding<SUP> </SUP>of gene expression, cell surface proteins, and =
drug=20
sensitivities<SUP> </SUP>of these cells. One long-recognized property of =
cancer=20
cells<SUP> </SUP>is anchorage independence=97as measured in vitro by =
the<SUP>=20
</SUP>ability of tumor cells to proliferate into colonies in soft<SUP>=20
</SUP>agar medium <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R2">2=
</A>)</I>.=20
Interestingly, the only normal cells with this<SUP> </SUP>property are =
stem=20
cells, and only a fraction of cells in a tumor<SUP> </SUP>cell culture =
can form=20
a colony in soft agar. This clonogenicity<SUP> </SUP>ranges from less =
that 1% to=20
20%=9650% (Michael Alley, personal<SUP> </SUP>communication). A likely =
explanation=20
of these data is that the<SUP> </SUP>only cells in a tumor cell line =
forming=20
colonies are the tumor<SUP> </SUP>stem cells, the rest of the cells in =
the tumor=20
being committed<SUP> </SUP>to differentiation or senescence. In fact, =
the=20
fraction of (SP)<SUP> </SUP>cells in tumor cell lines correlates with =
their=20
clonogenicty,<SUP> </SUP>in the few lines that have been examined [data =
not=20
shown but<SUP> </SUP>reported in <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R9">9=
</A>)</I>].=20
An exciting implication of this result is<SUP> </SUP>that by screening =
for drugs=20
suppressing colony formation, we<SUP> </SUP>can identify drugs that =
inhibit the=20
proliferation of tumor stem<SUP> </SUP>cells. Such an assay would be =
more=20
cumbersome and have a lower<SUP> </SUP>throughput than screens on =
adherent cells=20
but could prove to<SUP> </SUP>be more informative.<SUP> </SUP>
<P>Stem cells, especially germ cells, possess the ability to =
migrate<SUP>=20
</SUP>throughout the developing body. This is particularly true of<SUP>=20
</SUP>cells derived from the neural crest that give rise to =
melanoma,<SUP>=20
</SUP>neuroblastoma, and small cell lung cancers. Most of the =
mortality<SUP>=20
</SUP>of cancer arises from the metastasis of cells from the =
original<SUP>=20
</SUP>tumor site, and their migration to other organs. Could the =
metastatic<SUP>=20
</SUP>ability of some tumor cells relate to an innate property of<SUP>=20
</SUP>stem cells to migrate? If so, then further understanding of<SUP>=20
</SUP>germ cell migration could lead to new insights into =
metastasis.<SUP>=20
</SUP>
<P><A name=3DSEC5><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp; T<FONT=20
      size=3D-2>REATMENT</FONT> I<FONT size=3D-2>MPLICATIONS</FONT>=20
  </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#top">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>TOP<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#ABS">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Summary<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC1"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>The Cancer Stem Cell...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC2"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Normal and Abnormal Stem...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC3"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Stem Cell Activation and...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC4"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Research Implications<BR></A><IMG height=3D9 alt=3D" " =
hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT color=3D#464c53>Treatment =
Implications</FONT><BR><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC6"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      border=3D0>Conclusions<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#BIBL"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      =
border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>I=
n the=20
light of a stem cell model, tumors that regress following<SUP> =
</SUP>radiation=20
and chemotherapy protocols are not the result of a<SUP> </SUP>rare cell =
from=20
within the tumor but are the regrowth of the<SUP> </SUP>cancer stem =
cells in the=20
original tumor. However, tumor stem<SUP> </SUP>cells could acquire =
additional=20
genetic changes to render them<SUP> </SUP>even more drug resistant, =
radiation=20
resistant, or aneuploid.<SUP> </SUP>Because cures are achieved for many =
types of=20
cancer, cancer<SUP> </SUP>stem cells must be eliminated by some =
therapeutic=20
strategies.<SUP> </SUP>The committed cells in a tumor may very well play =
a role=20
in<SUP> </SUP>supporting or stimulating the stem cells, and regression =
of<SUP>=20
</SUP>the committed cells in a tumor could lead to elimination of<SUP> =
</SUP>the=20
stem cells as well. Immune surveillance is clearly important<SUP> =
</SUP>in many=20
cancers <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R44">=
44</A>)</I>,=20
and decreasing the mass of the tumor may<SUP> </SUP>allow the immune =
system to=20
efficiently recognize the remaining<SUP> </SUP>cells. Clearly, targeted=20
therapies that directly suppress or<SUP> </SUP>kill the tumor stem cells =
may=20
have increased efficacy. For example,<SUP> </SUP>angiogenesis is likely =
to be=20
critical to provide blood supply<SUP> </SUP>to the tumor stem cells, so=20
strategies to fight the development<SUP> </SUP>or inhibit the tumors =
blood=20
vessels are likely to be effective<SUP> </SUP><I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R45">=
45</A>)</I>.<SUP>=20
</SUP>
<P>Therapies that target cancer stem cells, however, may require<SUP> =
</SUP>new=20
approaches to evaluating the success of a cancer agent.<SUP> </SUP>If a =
drug=20
only inhibits the proliferation of the cancer stem<SUP> </SUP>cells =
(rather than=20
killing them outright) the drug will affect<SUP> </SUP>the growth of =
only a=20
minor population of cells and there may<SUP> </SUP>be a minimal decrease =
in the=20
growth of the tumor in the short<SUP> </SUP>term. Pharmacodynamic assays =
to=20
demonstrate the drug is inhibiting<SUP> </SUP>the target protein will be =

important and the use of endpoints<SUP> </SUP>such as disease free =
survival may=20
be useful. Cancer stem cell=96targeted<SUP> </SUP>therapies will no =
doubt be=20
combined with standard therapies,<SUP> </SUP>to attempt the complete =
elimination=20
of the tumor. As with all<SUP> </SUP>cancer therapies it will be =
critical to=20
establish a dose and<SUP> </SUP>schedule where the tumor is suppressed =
or=20
eliminated without<SUP> </SUP>undue toxicity of normal stem cells. =
Recent data=20
on mouse leukemia<SUP> </SUP>models suggest that such therapies may be=20
established <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R46">=
46</A>)</I>.<SUP>=20
</SUP>
<P>One of the innate resistance mechanisms of stem cells is the<SUP>=20
</SUP>expression of one or more ATP-binding cassette (ABC) =
transporters.<SUP>=20
</SUP>These pumps play a role in protecting stem cells from =
xenobiotic<SUP>=20
</SUP>toxins <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R47">=
47</A>).=20
ABCG2</I> and <I>ABCB1/MDR1</I> genes are expressed in the<SUP> =
</SUP>vast=20
majority of stem cells and in most tumor stem cells <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R11">=
11</A>=96<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R13">=
13</A>)</I>.<SUP>=20
</SUP>These transporters can efflux fluorescent dyes such as =
rhodamine<SUP>=20
</SUP>and Hoecht 33342, and this property allows the stem cells to<SUP> =
</SUP>be=20
separated from non-stem cells on a cell sorter <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R48">=
48</A>)</I>.=20
The<SUP> </SUP>combined use of chemotherapy drugs and ABC transporter=20
inhibitors<SUP> </SUP>could be used to specifically target cancer stem =
cells=20
<I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R49">=
49</A>,<SUP>=20
</SUP><A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R50">=
50</A>)</I>.=20
In fact, there are highly specific inhibitors of ABCB1<SUP> </SUP>in =
clinical=20
use and ABCG2 inhibitors in development <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R51">=
51</A>)</I>.=20
These<SUP> </SUP>therapies would be predicted to have toxic effects on =
the=20
patient=92s<SUP> </SUP>normal stem cells, and both ABCG2 and ABCB1 play =
a role in=20
the<SUP> </SUP>blood-brain barrier, which suggests that this approach =
would<SUP>=20
</SUP>have to be carefully titrated to avoid excessive toxicity.<SUP> =
</SUP>
<P>Directly targeting the growth of stem cells could be a fruitful<SUP>=20
</SUP>avenue. Because of ground-breaking work in <I>Drosophila</I> and=20
other<SUP> </SUP>developmental systems, we know a great deal about the=20
growth<SUP> </SUP>regulatory pathways operative in embryonic cells =
<I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R52">=
52</A>)</I>.=20
One such<SUP> </SUP>pathway, involving the Hedgehog (HH) and WNT =
signaling=20
molecules,<SUP> </SUP>contains a large number of genes that can act as =
tumor=20
suppressor<SUP> </SUP>genes or oncogenes in mammalian cells <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R5">5=
</A>)</I>.=20
For example, <I>Patched<SUP> </SUP>(PTCH)</I> codes for the receptor =
that binds=20
HH molecules and is<SUP> </SUP>mutated in patients with nevoid basal =
cell=20
carcinoma syndrome<SUP> </SUP><I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R53">=
53</A>,=20
<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R54">=
54</A>).=20
PTCH</I> is also mutated in nearly all sporadic basal<SUP> </SUP>cell =
carcinomas=20
and in some medulloblastomas <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R55">=
55</A>)</I>.=20
The mammalian<SUP> </SUP>HH genes (sonic hedgehog (SHH), Indian hedgehog =
(IHH),=20
and desert<SUP> </SUP>hedgehog (DHH)) are overexpressed in a wide =
variety of=20
cancers,<SUP> </SUP>including small-cell lung, pancreas, gastric, =
breast, and=20
prostate<SUP> </SUP><I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R56">=
56</A>=96<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R59">=
59</A>).=20
HH</I> family overexpression and PTCH mutation both<SUP> </SUP>have the =
effect=20
of constitutive action of <I>smoothened (SMO)</I> a<SUP> </SUP>G =
protein=96coupled=20
receptor that is a key signaling component<SUP> </SUP>of the pathway.=20
Constitutive <I>HH</I> family expression could lead<SUP> </SUP>to stem =
cell=20
activation and appears to be a common feature of<SUP> </SUP>many =
cancers.<SUP>=20
</SUP>
<P>Cyclopamine is a compound originally discovered in the Corn<SUP> =
</SUP>Lily=20
<I>(Veratrum californicum)</I>, a plant teratogenic to sheep <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R60">=
60</A>)</I>.<SUP>=20
</SUP>Cyclopamine specifically inhibits the SMO protein and can =
suppress<SUP>=20
</SUP>the growth of cells and tumors that contain activated HH <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R61">=
61</A>)</I>.<SUP>=20
</SUP>Human prostate tumors grown as xenografts in mice were =
completely<SUP>=20
</SUP>eliminated following twenty-one days of treatment with =
cyclopamine<SUP>=20
</SUP><I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R59">=
59</A>)</I>,=20
and UV-induced basal cell carcinomas were suppressed in<SUP> </SUP>mice =
given=20
low levels of cyclopamine in their drinking water<SUP> </SUP><I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R62">=
62</A>)</I>.=20
Both cyclopamine and SMO inhibitors are in development<SUP> </SUP>as =
anti-cancer=20
agents.<SUP> </SUP>
<P>The Notch protein is another protein important to the growth<SUP> =
</SUP>and=20
differentiation of stem cells. Notch is processed by the<SUP> =
</SUP>enzyme <IMG=20
alt=3D{gamma} src=3D"http://molinterv.aspetjournals.org/math/gamma.gif"=20
border=3D0>-secretase, the same enzyme that processes the APP =
protein<SUP>=20
</SUP>important in Alzheimer Disease. Several companies have =
developed<SUP>=20
</SUP><IMG alt=3D{gamma} =
src=3D"http://molinterv.aspetjournals.org/math/gamma.gif"=20
border=3D0>-secretase inhibitors and these drugs may have =
applications<SUP>=20
</SUP>to cancer therapy. Rapamycin is a bacterially derived =
molecule<SUP>=20
</SUP>that inhibits the target of rapamycin (TOR) family of kinases<SUP> =

</SUP><I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R63">=
63</A>)</I>.=20
Rapamycin has immunosuppressive properties and is also<SUP> </SUP>used =
to treat=20
certain leukemias <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R64">=
64</A>)</I>.=20
Yilmaz et al. have shown<SUP> </SUP>that rapamycin can selectively =
inhibit=20
leukemia initiating cells<SUP> </SUP>in leukemias generated in mice =
harboring a=20
conditional deletion<SUP> </SUP>of PTEN (phosphatase and tensin homolog =
deleted=20
on chromosome<SUP> </SUP>10), a phosphati-dylinositol phosphate (PIP)=20
phosphatase often<SUP> </SUP>mutated in human tumors <I>(<A=20
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#R46">=
46</A>)</I>.=20
Rapamycin depletes the leukemia-initiating<SUP> </SUP>cells while =
restoring the=20
normal hematopoieitc stem cells, suggesting<SUP> </SUP>therapies can be =
devised=20
specific for cancer stem cells. Additional<SUP> </SUP>strategies to =
directly=20
target the growth of tumor stem cells<SUP> </SUP>can now be developed =
and may=20
prove superior in effectiveness.<SUP> </SUP>
<P>Nearly all cancer mortality derives from metastatic leasions,<SUP> =
</SUP>not=20
the primary tumor. Therefore it is of great importance to<SUP> =
</SUP>understand=20
the nature of metastases and how to inhibit or eliminate<SUP> =
</SUP>them. It=20
follows from the cancer stem cell model that metastatic<SUP> =
</SUP>lesions must=20
initiate from a cancer stem cell. In fact many<SUP> </SUP>stem cells, =
such as=20
those in the neural crest, migrate through<SUP> </SUP>the developing =
body. Thus=20
the migratory behavior that we recognize<SUP> </SUP>as metastasis may be =
a=20
"normal" function of the cancer stem<SUP> </SUP>cell. Therefore drugs =
that=20
inhibit the growth of cancer stem<SUP> </SUP>cells may have the effect =
of=20
suppressing metastasis. Although<SUP> </SUP>the ultimate goal of cancer =
therapy=20
is the complete elimination<SUP> </SUP>of the tumor, turning cancer from =
an=20
acute disease to a chromic<SUP> </SUP>disease may be a more achievable =
near-term=20
prospect.<SUP> </SUP>
<P><A name=3DSEC6><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp; C<FONT=20
      size=3D-2>ONCLUSIONS</FONT> </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#top">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>TOP<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#ABS">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Summary<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC1"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>The Cancer Stem Cell...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC2"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Normal and Abnormal Stem...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC3"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Stem Cell Activation and...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC4"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Research Implications<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC5"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Treatment Implications<BR></A><IMG height=3D9 alt=3D" " =
hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT color=3D#464c53>Conclusions</FONT><BR><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#BIBL"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/darrow.gif" =
width=3D11=20
      =
border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>T=
he=20
concept of cancer as a stem cell disease has the potential<SUP> </SUP>to =

dramatically change our view of the problem. By separating<SUP> =
</SUP>the=20
disease into a stem cell activation phase and a tumor progression<SUP>=20
</SUP>phase, historical cancer studies can be reinterpreted with =
new<SUP>=20
</SUP>understanding. Research efforts to understand the growth of<SUP>=20
</SUP>tumor stem cells as well as identify tumor stem cell antigens<SUP> =

</SUP>could lead to new targeted approaches. Cancer diagnostics,=20
prevention,<SUP> </SUP>and therapeutics are likely to be greatly aided =
by this=20
new<SUP> </SUP>insight. Normal stem cells are being intensively studied =
to<SUP>=20
</SUP>develop approaches for replacing damaged cells and tissues in<SUP> =

</SUP>the body. The insight from this work is likely to aid the=20
understanding<SUP> </SUP>of cancer stem cells.<SUP> </SUP>
<P><A name=3DF4><!-- null --></A><BR clear=3Dleft>
<TABLE cellSpacing=3D0 cellPadding=3D4 width=3D"1%" bgColor=3D#ffffff>
  <TBODY>
  <TR>
    <TD>
      <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"1%" =
bgColor=3D#ffffff border=3D0>
        <TBODY>
        <TR>
          <TD bgColor=3D#eeeeee><FONT face=3D"arial, helvetica" =
size=3D-1><IMG=20
            height=3D200 alt=3D"Figure 4"=20
            =
src=3D"http://molinterv.aspetjournals.org/content/vol6/issue3/images/medi=
um/Dean_Mike.gif"=20
            width=3D186 border=3D0> </FONT></TD></TR>
        <TR>
          <TD bgColor=3D#eeeeee><FONT face=3D"arial, helvetica" =
size=3D-1><B>Michael=20
            Dean,<SUP> </SUP>PhD</B>, received his doctorate degree from =
the=20
            Biochemistry Department<SUP> </SUP>at the Boston University =
School=20
            of Medicine. His advisor was<SUP> </SUP>Dr. Gail Sonenshein =
and he=20
            studied transcription and regulation<SUP> </SUP>of the MYC =
oncogene.=20
            He performed his postdoctoral studies at<SUP> </SUP>the=20
            NCI-Frederick with Dr. George Vande Woude where he =
studied<SUP>=20
            </SUP>the MET oncogene. They discovered linkage of MET to =
the=20
            locus<SUP> </SUP>for cystic fibrosis. After joining the =
Laboratory=20
            of Genomic<SUP> </SUP>Diversity (LGD), Dr. Dean=92s group =
participated=20
            in the<SUP> </SUP>molecular cloning of the cystic fibrosis =
gene,=20
            identification<SUP> </SUP>of variants in CCR5 and CCR2 =
involved in=20
            HIV-1 infection and<SUP> </SUP>AIDS progression, =
identification of=20
            the VHL and PTCH genes in<SUP> </SUP>inherited cancers, and =
the=20
            involvement of several ATP-binding<SUP> </SUP>cassette (ABC) =

            transporters in human disease and drug resistance.<SUP> =
</SUP>He is=20
            shown here teaching as part of the Elementary Outreach<SUP>=20
            </SUP>Program. This is an effort Michael created bringing =
NCI=20
            and<SUP> </SUP>contract employees into Frederick County =
elementary=20
            schools.<SUP> </SUP>Over 7,000 students have received =
hands-on=20
            science lessons in<SUP> </SUP>the six years the program has =
been=20
            operating. In his spare time<SUP> </SUP>Michael enjoys =
kayaking,=20
            skiing and playing softball. He is<SUP> </SUP>Chief of the =
Human=20
            Genetics Section in the LGD. E-mail: <SPAN=20
            id=3Dem0>dean{at}ncifcrf.gov</SPAN>
            <SCRIPT type=3Dtext/javascript><!--=0A=
 var u =3D "dean", d =3D "ncifcrf.gov"; =
document.getElementById("em0").innerHTML =3D '<a href=3D"mailto:' + u + =
'@' + d + '">' + u + '@' + d + '<\/a>'//--></SCRIPT>
            ;<SUP> </SUP>fax: 301-846-1909.
            =
<P></FONT></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE><SUP></=
SUP>
<P><A name=3DBIBL><!-- null --></A><BR clear=3Dright>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG =
height=3D21=20
      alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/rarrow.gif" =
width=3D10></TD>
    <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT =
size=3D+2>&nbsp;&nbsp;=20
      References </FONT></TH></TR></TBODY></TABLE>
<TABLE cellPadding=3D5 align=3Dright border=3D1>
  <TBODY>
  <TR>
    <TH align=3Dleft><FONT size=3D-1><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#top">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>TOP<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#ABS">=
<IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Summary<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC1"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>The Cancer Stem Cell...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC2"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Normal and Abnormal Stem...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC3"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Stem Cell Activation and...<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC4"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Research Implications<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC5"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Treatment Implications<BR></A><A=20
      =
href=3D"http://molinterv.aspetjournals.org/cgi/content/full/6/3/140#SEC6"=
><IMG=20
      height=3D9 alt=3D" " hspace=3D5=20
      src=3D"http://molinterv.aspetjournals.org/icons/toc/uarrow.gif" =
width=3D11=20
      border=3D0>Conclusions<BR></A><IMG height=3D9 alt=3D" " hspace=3D5 =

      src=3D"http://molinterv.aspetjournals.org/icons/toc/dot.gif" =
width=3D11=20
      border=3D0><FONT=20
color=3D#464c53>References</FONT><BR></FONT></TH></TR></TBODY></TABLE>&nb=
sp;<BR>
<OL compact><A name=3DR1><!-- null --></A>
  <LI value=3D1>Mintz, B. and Illmensee, K. Normal genetically mosaic =
mice=20
  produced from malignant teratocarcinoma cells. <I>Proc. Natl. Acad. =
Sci.=20
  U.S.A.</I> <B>72</B>, 3585=963589 (1975).<!-- HIGHWIRE =
ID=3D"6:3:140:1" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dpnas&amp;resid=3D72/9/3585"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR2><!-- null --></A>
  <LI value=3D2>Hamburger, A.W. and Salmon, S.E. Primary bioassay of =
human tumor=20
  stem cells. <I>Science</I> <B>197</B>, 461=96463 (1977). <B>Review of =
tumor=20
  suppressor genes proving three classifications of tumors and the =
relevance of=20
  stem cells.</B><!-- HIGHWIRE ID=3D"6:3:140:2" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dsci&amp;resid=3D197/4302/461"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR3><!-- null --></A>
  <LI value=3D3>Knudson, A.G. Antioncogenes and human cancer. <I>Proc. =
Natl. Acad.=20
  Sci. U.S.A.</I> <B>90</B>, 10914=9610921=20
  (1993).<!-- HIGHWIRE ID=3D"6:3:140:3" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dpnas&amp;resid=3D90/23/10914"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR4><!-- null --></A>
  <LI value=3D4>Lapidot, T., C. Sirard, J. Vormoor et al. A cell =
initiating human=20
  acute myeloid leukaemia after transplantation into SCID mice. =
<I>Nature</I>=20
  <B>367</B>, 645=96648 (1994). <B>The first isolation of leukemia stem =
cells.</B><!-- HIGHWIRE ID=3D"6:3:140:4" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/367645a0&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
7509044&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR5><!-- null --></A>
  <LI value=3D5>Dean, M. Towards a unified model of tumor suppression: =
Lessons=20
  learned from the human patched gene. <I>Biochim. Biophys. Acta</I>=20
  <B>1332</B>, M43=96M52 (1997). <B>Review of the role of the PTCH gene =
in cancer=20
  and the inovolvement of PTCH in the stimulation of skin stem =
cells.</B><!-- HIGHWIRE ID=3D"6:3:140:5" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
9141460&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR6><!-- null --></A>
  <LI value=3D6>Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., =
Morrison, S.J.,=20
  and Clarke, M.F. Prospective identification of tumorigenic breast =
cancer=20
  cells. <I>Proc. Natl. Acad. Sci. U.S.A.</I> <B>100</B>, 3983=963988 =
(2003).=20
  <B>The first isolation of cancer stem cells in a solid tumor.</B><!-- =
HIGHWIRE ID=3D"6:3:140:6" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dpnas&amp;resid=3D100/7/3983"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR7><!-- null --></A>
  <LI value=3D7>Hemmati, H.D., Nakano, I, Lazareff, J.A., =
Masterman-Smith, M.,=20
  Geschwind, D.H., Bronner-Fraser, M., and Kornblum, H.I. Cancerous stem =
cells=20
  can arise from pediatric brain tumors. <I>Proc. Natl. Acad. Sci. =
U.S.A.</I>=20
  <B>100</B>, 15178=9615183 (2003).<!-- HIGHWIRE ID=3D"6:3:140:7" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dpnas&amp;resid=3D100/25/15178"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR8><!-- null --></A>
  <LI value=3D8>Kondo, T., Setoguchi, T., and Taga, T. Persistence of a =
small=20
  subpopulation of cancer stem-like cells in the C6 glioma cell line. =
<I>Proc.=20
  Natl. Acad. Sci. U.S.A.</I> <B>101</B>, 781=96786 (2004).<!-- HIGHWIRE =
ID=3D"6:3:140:8" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dpnas&amp;resid=3D101/3/781"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR9><!-- null --></A>
  <LI value=3D9>Hirschmann-Jax, C., Foster, A.E., Wulf, G.G., Nuchtern, =
J.G., Jax,=20
  T.W., Gobel, U., Goodell, M.A., and Brenner, M.K. A distinct "side =
population"=20
  of cells with high drug efflux capacity in human tumor cells. <I>Proc. =
Natl.=20
  Acad. Sci. U.S.A.</I> <B>101</B>, 14228=9614233 (2004).<!-- HIGHWIRE =
ID=3D"6:3:140:9" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dpnas&amp;resid=3D101/39/14228"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR10><!-- null --></A>
  <LI value=3D10>Thomlinson, R.H. and Gray, L.H. The histological =
structure of=20
  some human lung cancers and the possible implications for =
radiotherapy. <I>Br.=20
  J. Cancer</I> <B>9</B>, 539=96549 (1955).<!-- HIGHWIRE =
ID=3D"6:3:140:10" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
13291483&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR11><!-- null --></A>
  <LI value=3D11>Zhou, S., Schuetz, J.D., Bunting, K.D. et al. The ABC =
transporter=20
  Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a =
molecular=20
  determinant of the side-population phenotype. <I>Nat. Med.</I> =
<B>7</B>,=20
  1028=961034 (2001).<!-- HIGHWIRE ID=3D"6:3:140:11" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/nm0901-1028&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
11533706&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR12><!-- null --></A>
  <LI value=3D12>Scharenberg, C.W., Harkey, M.A., and Torok-Storb, B. =
The ABCG2=20
  transporter is an efficient Hoechst 33342 efflux pump and is =
preferentially=20
  expressed by immature human hematopoietic progenitors. <I>Blood</I> =
<B>99</B>,=20
  507=96512 (2002).<!-- HIGHWIRE ID=3D"6:3:140:12" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dbloodjournal&amp;resid=3D99/2/507"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR13><!-- null --></A>
  <LI value=3D13>Kim, M., Turnquist, H., Jackson, J., Sgagias, M., Yan, =
Y., Gong,=20
  M., Dean, M., Sharp, J.G., and Cowan, K. The multidrug resistance =
transporter=20
  ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and =
is=20
  overexpressed in hematopoietic stem cells. <I>Clin. Cancer Res.</I> =
<B>8</B>,=20
  22=9628 (2002).<!-- HIGHWIRE ID=3D"6:3:140:13" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dclincanres&amp;resid=3D8/1/22"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR14><!-- null --></A>
  <LI value=3D14>Till, J.E., McCulloch, E.A., and Siminovitch, L. A =
stochastic=20
  model of stem cell proliferation, based on the growth of spleen =
colony-forming=20
  cells. <I>Proc. Natl. Acad. Sci. U.S.A.</I> <B>51</B>, 29=9636 =
(1964).<!-- HIGHWIRE ID=3D"6:3:140:14" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DPDF&amp;=
journalCode=3Dpnas&amp;resid=3D51/1/29"><NOBR>[<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR15><!-- null --></A>
  <LI value=3D15>Rizvi, A.Z., Swain, J.R., Davies, P.S., Bailey, A.S., =
Decker,=20
  A.D., Willenbring, H., Grompe, M., Fleming, W.H., and Wong, M.H. Bone=20
  marrow-derived cells fuse with normal and transformed intestinal stem =
cells.=20
  <I>Proc. Natl. Acad. Sci. U.S.A.</I> <B>103</B>, 6321=966325 =
(2006).<!-- HIGHWIRE ID=3D"6:3:140:15" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dpnas&amp;resid=3D103/16/6321"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR16><!-- null --></A>
  <LI value=3D16>Beachy, P.A., Karhadkar, S.S., and Berman, D.M. Tissue =
repair and=20
  stem cell renewal in carcinogenesis. <I>Nature</I> <B>432</B>, =
324=96331 (2004).=20
  <B>Review article on the importance of tissue damage to the initiation =
of=20
  cancer.</B><!-- HIGHWIRE ID=3D"6:3:140:16" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/nature03100&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
15549094&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR17><!-- null --></A>
  <LI value=3D17>Tennant, R. What is a tumor promoter? <I>Environ. =
Health=20
  Perspect.</I> <B>107</B>, A390=96A391 (1999).<!-- HIGHWIRE =
ID=3D"6:3:140:17" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10417370&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR18><!-- null --></A>
  <LI value=3D18>Knudson, A.G., Mutation and cancer: Statistical study =
of=20
  retinoblastoma. <I>Proc. Natl. Acad. Sci. U.S.A.</I> <B>68</B>, =
820=96823=20
(1971).<!-- HIGHWIRE ID=3D"6:3:140:18" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dpnas&amp;resid=3D68/4/820"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR19><!-- null --></A>
  <LI value=3D19>Trichopoulos, D., Lagiou, P., and Adami, H.O. Towards =
an=20
  integrated model for breast cancer etiology: the crucial role of the =
number of=20
  mammary tissue-specific stem cells. <I>Breast Cancer Res.</I> =
<B>7</B>, 13=9617=20
  (2005).<!-- HIGHWIRE ID=3D"6:3:140:19" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1186/bcr966&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
15642176&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR20><!-- null --></A>
  <LI value=3D20>Gail, M.H., Brinton, L.A., Byar, D.P., Corle, D.K., =
Green, S.B.,=20
  Schairer, C., and Mulvihill, J.J. Projecting individualized =
probabilities of=20
  developing breast cancer for white females who are being examined =
annually.=20
  <I>J. Natl. Cancer Inst.</I> <B>81</B>, 1879=961886 (1989).<!-- =
HIGHWIRE ID=3D"6:3:140:20" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Djnci&amp;resid=3D81/24/1879"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR21><!-- null --></A>
  <LI value=3D21>Kauff, N.D., Satagopan, J.M., Robson. M.E. et al. =
Risk-reducing=20
  salpin-go-oophorectomy in women with a BRCA1 or BRCA2 mutation. <I>N. =
Engl. J.=20
  Med.</I> <B>346</B>, 1609=961615 (2002).<!-- HIGHWIRE =
ID=3D"6:3:140:21" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dnejm&amp;resid=3D346/21/1609"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR22><!-- null --></A>
  <LI value=3D22>Eaden, J. Colorectal carcinoma and inflammatory bowel =
disease.=20
  <I>Aliment. Pharmacol. Ther.</I> <B>20</B> <B>Suppl 4</B>, 24=9630 =
(2004).<!-- HIGHWIRE ID=3D"6:3:140:22" --><!-- /HIGHWIRE --><A =
name=3DR23><!-- null --></A>
  <LI value=3D23>Gardner, E.J. Follow-up study of a family group =
exhibiting=20
  dominant inheritance for a syndrome including intestinal polyps, =
osteomas,=20
  fibromas and epidermal cysts. <I>Am. J. Hum. Genet.</I> <B>14</B>, =
376=96390=20
  (1962).<!-- HIGHWIRE ID=3D"6:3:140:23" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
13946545&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR24><!-- null --></A>
  <LI value=3D24>Nishisho, I., Nakamura, Y., Miyoshi, Y. et al. =
Mutations of=20
  chromosome 5q21 genes in FAP and colorectal cancer patients. =
<I>Science</I>=20
  <B>253</B>, 665=96669 (1991).<!-- HIGHWIRE ID=3D"6:3:140:24" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dsci&amp;resid=3D253/5020/665"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR25><!-- null --></A>
  <LI value=3D25>Groden, J. Identification and characterization of the =
familial=20
  adenomatous polyposis coli gene. <I>Cell</I> <B>66</B>, 589=96600 =
(1991).<!-- HIGHWIRE ID=3D"6:3:140:25" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1016/0092-8674(81)90021-0&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
1651174&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR26><!-- null --></A>
  <LI value=3D26>Deschner, E.E. and Lipkin, M. Proliferative patterns in =
colonic=20
  mucosa in familial polyposis. <I>Cancer</I> <B>35</B>, 413=96418 =
(1975).<!-- HIGHWIRE ID=3D"6:3:140:26" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1002/1097-0142(197502)35:2<413::AID-CNCR2820350217>3.0.CO;2-B&amp;link=
_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
1111917&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR27><!-- null --></A>
  <LI value=3D27>Su, L.K., Kinzler, K.W., Vogelstein, B., Preisinger, =
A.C., Moser,=20
  A.R., Luongo, C., Gould, K.A., and Dove, W.F. Multiple intestinal =
neoplasia=20
  caused by a mutation in the murine homolog of the APC gene. =
<I>Science</I>=20
  <B>256</B>, 668=96670 (1992).<!-- HIGHWIRE ID=3D"6:3:140:27" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dsci&amp;resid=3D256/5057/668"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR28><!-- null --></A>
  <LI value=3D28>Moser, A.R., Dove, W.F., Roth, K.A., and Gordon, J.I. =
The Min=20
  (multiple intestinal neoplasia) mutation: Its effect on gut epithelial =
cell=20
  differentiation and interaction with a modifier system. <I>J. Cell =
Biol.</I>=20
  <B>116</B>, 1517=961526 (1992).<!-- HIGHWIRE ID=3D"6:3:140:28" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Djcb&amp;resid=3D116/6/1517"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR29><!-- null --></A>
  <LI value=3D29>Kinzler, K.W. and Vogelstein, B. Lessons from =
hereditary=20
  colorectal cancer. <I>Cell</I> <B>87</B>, 159=96170 (1996).<!-- =
HIGHWIRE ID=3D"6:3:140:29" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1016/S0092-8674(00)81333-1&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
8861899&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR30><!-- null --></A>
  <LI value=3D30>Beasley, R.P., Hwang, L.Y., Lin, C.C., and Chien, C.S.=20
  Hepatocellular carcinoma and hepatitis B virus. A prospective study of =
22 707=20
  men in Taiwan. <I>Lancet</I> <B>2</B>, 1129=961133 (1981).<!-- =
HIGHWIRE ID=3D"6:3:140:30" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1016/S0140-6736(81)90585-7&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
6118576&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR31><!-- null --></A>
  <LI value=3D31>Yu, M.C., Tong, M.J., Coursaget, P., Ross, R.K., =
Govindarajan,=20
  S., and Henderson, B.E. Prevalence of hepatitis B and C viral markers =
in black=20
  and white patients with hepatocellular carcinoma in the United States. =
<I>J.=20
  Natl. Cancer Inst.</I> <B>82</B>, 1038=961041 (1990).<!-- HIGHWIRE =
ID=3D"6:3:140:31" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Djnci&amp;resid=3D82/12/1038"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR32><!-- null --></A>
  <LI value=3D32>Hughes, J. and Weil, H. <I>Epidemiology of Lung Cancer, =
in Lung=20
  Biology in Health and Disease</I>, J. Samet, Editor. 1994, Marcel =
Dekker: New=20
  York. pp. 185=96205.<!-- HIGHWIRE ID=3D"6:3:140:32" --><!-- /HIGHWIRE =
--><A=20
  name=3DR33><!-- null --></A>
  <LI value=3D33>Knudson, A. Asbestos and mesothelioma: Genetic lessons =
from a=20
  tragedy. <I>Proc. Natl. Acad. Sci. U.S.A.</I> <B>92</B>, 10819=9610820 =
(1995).<!-- HIGHWIRE ID=3D"6:3:140:33" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DPDF&amp;=
journalCode=3Dpnas&amp;resid=3D92/24/10819"><NOBR>[<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR34><!-- null --></A>
  <LI value=3D34>Wu-Williams, A.H., Yu, M.C., and Mack, T.M. Life-style, =

  workplace, and stomach cancer by subsite in young men of Los Angeles =
County.=20
  <I>Cancer Res.</I> <B>50</B>, 2569=962576 (1990).<!-- HIGHWIRE =
ID=3D"6:3:140:34" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dcanres&amp;resid=3D50/9/2569"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR35><!-- null --></A>
  <LI value=3D35>Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., =
Yamaguchi,=20
  S., Yamakido, M., Taniyama, K., Sasaki, N., and Schlemper, R.J. =
Helicobacter=20
  pylori infection and the development of gastric cancer. <I>N. Engl. J. =

  Med.</I> <B>345</B>, 784=96789 (2001).<!-- HIGHWIRE ID=3D"6:3:140:35" =
--><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dnejm&amp;resid=3D345/11/784"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR36><!-- null --></A>
  <LI value=3D36>Michaud, D.S., Epidemiology of pancreatic cancer. =
<I>Minerva=20
  Chir.</I> <B>59</B>, 99=96111 (2004).<!-- HIGHWIRE ID=3D"6:3:140:36" =
--><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
15238885&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR37><!-- null --></A>
  <LI value=3D37>zur Hausen, H., Meinhof, W., Scheiber, W., and =
Bornkamm, G.W.=20
  Attempts to detect virus-secific DNA in human tumors. I. Nucleic acid=20
  hybridizations with complementary RNA of human wart virus. <I>Int. J.=20
  Cancer</I> <B>13</B>, 650=96656 (1974).<!-- HIGHWIRE ID=3D"6:3:140:37" =
--><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
4367340&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR38><!-- null --></A>
  <LI value=3D38>Werness, B.A., Levine, A.J., and Howley, P.M. =
Association of=20
  human papillomavirus types 16 and 18 E6 proteins with p53. =
<I>Science</I>=20
  <B>248</B>, 76=9679 (1990).<!-- HIGHWIRE ID=3D"6:3:140:38" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dsci&amp;resid=3D248/4951/76"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR39><!-- null --></A>
  <LI value=3D39>Tommasino, M. and Crawford, L. Human papillomavirus E6 =
and E7:=20
  Proteins which deregulate the cell cycle. Bioessays 17, 509=96518 =
(1995).<!-- HIGHWIRE ID=3D"6:3:140:39" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1002/bies.950170607&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
7575492&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR40><!-- null --></A>
  <LI value=3D40>Tindle, R.W. Immune evasion in human =
papillomavirus-associated=20
  cervical cancer. <I>Nat. Rev. Cancer</I> <B>2</B>, 59=9665 (2002).<!-- =
HIGHWIRE ID=3D"6:3:140:40" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/nrc700&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
11902586&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR41><!-- null --></A>
  <LI value=3D41>Sasadeusz, J., Kelly, H., Szer, J., Schwarer, A.P., =
Mitchell, H.,=20
  and Grigg, A. Abnormal cervical cytology in bone marrow transplant =
recipients.=20
  <I>Bone Marrow Transplant</I> <B>28</B>, 393=96397 (2001).<!-- =
HIGHWIRE ID=3D"6:3:140:41" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/sj.bmt.1703141&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
11571513&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR42><!-- null --></A>
  <LI value=3D42>Millward, M.J., Cantwell, B.M., Munro, N.C., Robinson, =
A.,=20
  Corris, P.A., and Harris, A.L. Oral verapamil with chemotherapy for =
advanced=20
  non-small cell lung cancer: A randomised study. <I>Br. J. Cancer</I>=20
  <B>67</B>, 1031=961035 (1993).<!-- HIGHWIRE ID=3D"6:3:140:42" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
8388231&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR43><!-- null --></A>
  <LI value=3D43>Alley, M.C., Scudiero, D.A., Monks, A. et al. =
Feasibility of drug=20
  screening with panels of human tumor cell lines using a microculture=20
  tetrazolium assay. <I>Cancer Res.</I> <B>48</B>, 589=96601 (1988).<!-- =
HIGHWIRE ID=3D"6:3:140:43" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dcanres&amp;resid=3D48/3/589"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR44><!-- null --></A>
  <LI value=3D44>Nakachi, K., Hayashi, T., Imai, K., and Kusunoki, Y. =
Perspectives=20
  on cancer immuno-epidemiology. <I>Cancer Sci.</I> <B>95</B>, 921=96929 =
(2004).<!-- HIGHWIRE ID=3D"6:3:140:44" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1111/j.1349-7006.2004.tb03178.x&amp;link_type=3DDOI">[CrossRef]</A><A =

  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
15596039&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR45><!-- null --></A>
  <LI value=3D45>Folkman, J. Role of angiogenesis in tumor growth and =
metastasis.=20
  <I>Semin. Oncol.</I> <B>29</B>, 15=9618=20
  (2002).<!-- HIGHWIRE ID=3D"6:3:140:45" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
11894003&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR46><!-- null --></A>
  <LI value=3D46>Yilmaz, O.H., Valdez, R., Theisen, B.K., Guo, W., =
Ferguson, D.O.,=20
  Wu, H., and Morrison, S.J. Pten dependence distinguishes =
haematopoietic stem=20
  cells from leukaemia-initiating cells. <I>Nature</I> <B>441</B>, =
475=96482=20
  (2006). <B>Demonstration of distinct properties of cancer stem cells =
and=20
  normal stem cells and a potential cancer stem cell-specific =
therapy.</B><!-- HIGHWIRE ID=3D"6:3:140:46" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/nature04703&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
16598206&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR47><!-- null --></A>
  <LI value=3D47>Gottesman, M.M., Fojo, T., and Bates, S.E. Multidrug =
resistance=20
  in cancer: role of ATP-dependent transporters. <I>Nat. Rev. Cancer</I> =

  <B>2</B>, 48=9658 (2002).<!-- HIGHWIRE ID=3D"6:3:140:47" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/nrc706&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
11902585&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR48><!-- null --></A>
  <LI value=3D48>Goodell, M.A., Brose, K., Paradis, G., Conner, A.S., =
and=20
  Mulligan, R.C. Isolation and functional properties of murine =
hematopoietic=20
  stem cells that are replicating in vivo. <I>J. Exp. Med.</I> =
<B>183</B>,=20
  1797=961806 (1996).<!-- HIGHWIRE ID=3D"6:3:140:48" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Djem&amp;resid=3D183/4/1797"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR49><!-- null --></A>
  <LI value=3D49>Dean, M., Fojo, T., and Bates, S. Tumour stem cells and =
drug=20
  resistance. <I>Nat. Rev. Cancer</I> <B>5</B>, 275=96284 (2005). =
<B>Review on the=20
  implications of cancer stem cells to chemotherapy resistance.</B><!-- =
HIGHWIRE ID=3D"6:3:140:49" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/nrc1590&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
15803154&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR50><!-- null --></A>
  <LI value=3D50>Dean, M. and Annilo, T. Evolution of the ATP-binding =
cassette=20
  (ABC) transporter superfamily in vertebrates. <I>Ann. Rev. Hum. Genet. =

  Genom.</I> <B>6</B>, 123=96142 2005.<!-- HIGHWIRE ID=3D"6:3:140:50" =
--><!-- /HIGHWIRE --><A name=3DR51><!-- null --></A>
  <LI value=3D51>Henrich, C.J., Bokesch, H.R., Dean, M., Bates, S.E., =
Robey, R.W.,=20
  Goncharova, E.I., Wilson, J.A., and McMahon, J.B. A high-throughput =
cell-based=20
  assay for inhibitors of ABCG2 activity. <I>J. Biomol. Screen.</I> =
<B>11</B>,=20
  176=96183 (2006).<!-- HIGHWIRE ID=3D"6:3:140:51" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dspjbx&amp;resid=3D11/2/176"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR52><!-- null --></A>
  <LI value=3D52>Nusslein-Volhard, C. and Wieschaus, E. Mutations =
affecting=20
  segment number and polarity in Drosophila. <I>Nature</I> <B>287</B>, =
795=96801=20
  (1980).<!-- HIGHWIRE ID=3D"6:3:140:52" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/287795a0&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
6776413&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR53><!-- null --></A>
  <LI value=3D53>Hahn, H., Wicking, C., Zaphiropoulous, P.G. et al. =
Mutations of=20
  the human homolog of Drosophila patched in the nevoid basal cell =
carcinoma=20
  syndrome. <I>Cell</I> <B>85</B>, 841=96851 (1996). <B>This article and =
the=20
  following one demonstrated that the PTCH gene is responsible for the =
inherited=20
  nevoid basal cell carcinoma and established PTCH as a tumor suppressor =

  gene.</B><!-- HIGHWIRE ID=3D"6:3:140:53" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1016/S0092-8674(00)81268-4&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
8681379&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR54><!-- null --></A>
  <LI value=3D54>Johnson, R.L., Rothman, A.L., Xie, J. et al. Human =
homolog of=20
  patched, a candidate gene for the Basal Cell Nevus Syndrome. =
<I>Science</I>=20
  <B>272</B>, 1668=961671 (1996).<!-- HIGHWIRE ID=3D"6:3:140:54" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dsci&amp;resid=3D272/5268/1668">[Abstract]</A><!-- =
/HIGHWIRE --><A=20
  name=3DR55><!-- null --></A>
  <LI value=3D55>Bale, A.E. and Yu, K.P. The hedgehog pathway and basal =
cell=20
  carcinomas. <I>Hum. Mol. Genet.</I> <B>10</B>, 757=96762 (2001).<!-- =
HIGHWIRE ID=3D"6:3:140:55" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dhmg&amp;resid=3D10/7/757"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR56><!-- null --></A>
  <LI value=3D56>Berman, D.M., Karhadkar, S.S., Maitra, A. et al. =
Widespread=20
  requirement for Hedgehog ligand stimulation in growth of digestive =
tract=20
  tumours. <I>Nature</I> <B>425</B>, 846=96851 (2003). <B>Paper =
implicating the=20
  Hedgehog pathway in several cancers and presenting pre-clinical data =
on the=20
  use of cyclopamine in cancer therapy.</B><!-- HIGHWIRE =
ID=3D"6:3:140:56" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/nature01972&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
14520411&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR57><!-- null --></A>
  <LI value=3D57>Watkins, D.N., Berman, D.M., Burkholder, S.G., Wang, =
B., Beachy,=20
  P.A., and Baylin, S.B. Hedgehog signalling within airway epithelial=20
  progenitors and in small-cell lung cancer. <I>Nature</I> <B>422</B>, =
313=96317=20
  (2003).<!-- HIGHWIRE ID=3D"6:3:140:57" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/nature01493&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
12629553&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR58><!-- null --></A>
  <LI value=3D58>Thayer, S.P., di Magliano, M.P., Heiser, P.W. et al. =
Hedgehog is=20
  an early and late mediator of pancreatic cancer tumorigenesis. =
<I>Nature</I>=20
  <B>425</B>, 851=96856 (2003).<!-- HIGHWIRE ID=3D"6:3:140:58" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/nature02009&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
14520413&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR59><!-- null --></A>
  <LI value=3D59>Karhadkar, S.S., Bova, G.S., Abdallah, N., Dhara, S., =
Gardner,=20
  D., Maitra, A., Isaacs, J.T., Berman, D.M., and Beachy, P.A. Hedgehog=20
  signalling in prostate regeneration, neoplasia and metastasis. =
<I>Nature</I>=20
  <B>431</B>, 707=96712 (2004).<!-- HIGHWIRE ID=3D"6:3:140:59" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1038/nature02962&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
15361885&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR60><!-- null --></A>
  <LI value=3D60>James, L.F., Panter, K.E., Gaffield, W., and Molyneux, =
R.J.=20
  Biomedical applications of poisonous plant research. <I>J. Agric. Food =

  Chem.</I> <B>52</B>, 3211=963230 (2004).<!-- HIGHWIRE =
ID=3D"6:3:140:60" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
10.1021/jf0308206&amp;link_type=3DDOI">[CrossRef]</A><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
15161174&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20
  name=3DR61><!-- null --></A>
  <LI value=3D61>Chen, J.K., Taipale, J., Cooper, M.K., and Beachy, P.A. =

  Inhibition of Hedgehog signaling by direct binding of cyclopamine to=20
  Smoothened. <I>Genes Dev.</I> <B>16</B>, 2743=962748 (2002).<!-- =
HIGHWIRE ID=3D"6:3:140:61" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dgenesdev&amp;resid=3D16/21/2743"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR62><!-- null --></A>
  <LI value=3D62>Athar, M., Li, C., Tang, X., et al. Inhibition of =
smoothened=20
  signaling prevents ultraviolet B-induced basal cell carcinomas through =

  regulation of Fas expression and apoptosis. <I>Cancer Res.</I> =
<B>64</B>,=20
  7545=967552 (2004).<!-- HIGHWIRE ID=3D"6:3:140:62" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dcanres&amp;resid=3D64/20/7545"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR63><!-- null --></A>
  <LI value=3D63>Podsypanina, K., Lee, R.T., Politis, C. et al. An =
inhibitor of=20
  mTOR reduces neoplasia and normalizes p70/S6 kinase activity in=20
  Pten<SUP>+/=96</SUP> mice. <I>Proc. Natl. Acad. Sci. U.S.A.</I> =
<B>98</B>,=20
  10320=9610325 (2001).<!-- HIGHWIRE ID=3D"6:3:140:63" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/ijlink?linkType=3DABST&amp=
;journalCode=3Dpnas&amp;resid=3D98/18/10320"><NOBR>[Abstract/<FONT=20
  color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- =
/HIGHWIRE --><A=20
  name=3DR64><!-- null --></A>
  <LI value=3D64>Recher, C., Dos Santos, C., Demur, C., and Payrastre, =
B. mTOR, a=20
  new therapeutic target in acute myeloid leukemia. <I>Cell Cycle</I> =
<B>4</B>,=20
  1540=961549 (2005).<!-- HIGHWIRE ID=3D"6:3:140:64" --><A=20
  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
16205124&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE =
--></LI></OL><BR=20
clear=3Dall><FONT face=3D""></FONT><BR clear=3Dall><BR clear=3Dall><BR =
clear=3Dall>
<TABLE class=3Dcontent_box_outer_table>
  <TBODY>
  <TR>
    <TD><!-- beginning of inner table -->
      <TABLE class=3Dcontent_box_inner_table><!-- citation -->
        <TBODY>
        <TR>
          <TD class=3Dcontent_box_title_highlight colSpan=3D2>This =
Article</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/content/abstract/6/3/140">=
Summary</A></STRONG>=20
            <IMG height=3D7 alt=3D"Freely available"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/toc/free.gif"=20
            width=3D32 border=3D0> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/reprint/6/3/140"><STRONG>F=
ull=20
            Text</STRONG> (PDF)</A> </STRONG></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/alerts/ctalert?alertType=3D=
citedby&amp;addAlert=3Dcited_by&amp;saveAlert=3Dno&amp;cited_by_criteria_=
resid=3Dmolint;6/3/140&amp;return_type=3Darticle&amp;return_url=3Dhttp%3A=
%2F%2Fmolinterv.aspetjournals.org%2Fcgi%2Fcontent%2Ffull%2F6%2F3%2F140">A=
lert=20
            me when this article is cited</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/alerts/ctalert?alertType=3D=
correction&amp;addAlert=3Dcorrection&amp;saveAlert=3Dno&amp;correction_cr=
iteria_value=3D6/3/140&amp;return_type=3Darticle&amp;return_url=3Dhttp%3A=
%2F%2Fmolinterv.aspetjournals.org%2Fcgi%2Fcontent%2Ffull%2F6%2F3%2F140">A=
lert=20
            me if a correction is posted</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>Services</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/search?qbe=3Dmolint;6/3/14=
0&amp;journalcode=3Dmolint&amp;minscore=3D5000">Similar=20
            articles in this journal</A> </STRONG></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
16809475&amp;link_type=3DMED_NBRS">Similar=20
            articles in PubMed</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/alerts/etoc">Alert me=20
            to new issues of the journal</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/citmgr?gca=3Dmolint;6/3/14=
0">Download=20
            to citation manager</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>Citing =
Articles</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
http://molinterv.aspetjournals.org/cgi/content/abstract/6/3/140&amp;link_=
type=3DGOOGLESCHOLAR"=20
            target=3D_blank>Citing Articles via Google =
Scholar</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>Google =
Scholar</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://scholar.google.com/scholar?q=3D%22author%3AM.+author%3ADea=
n%22"=20
            target=3D_blank>Articles by Dean, M.</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
http://molinterv.aspetjournals.org/cgi/content/abstract/6/3/140&amp;link_=
type=3DGOOGLESCHOLARRELATED"=20
            target=3D_blank>Search for Related Content</A></STRONG> =
</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_title colSpan=3D2>PubMed</TD></TR>
        <TR>
          <TD class=3Dcontent_box_space_between_sections =
colSpan=3D2><IMG height=3D1=20
            alt=3D" " =
src=3D"http://molinterv.aspetjournals.org/icons/spacer.gif"=20
            width=3D200></TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
16809475&amp;link_type=3DPUBMED">PubMed=20
            Citation</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG><A=20
            =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?access_num=3D=
Dean+M&amp;link_type=3DAUTHORSEARCH"=20
            target=3D_blank>Articles by Dean, M.</A></STRONG> </TD></TR>
        <TR>
          <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG =
height=3D11=20
            alt=3D"Right arrow"=20
            =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gi=
f"=20
            width=3D4 border=3D0></TD>
          <TD class=3Dcontent_box_item><STRONG=20
            class=3Dcontent_box_inner_title>Pubmed/NCBI =
databases</STRONG>
            <TABLE class=3Dcontent_box_inner_table style=3D"FONT-SIZE: =
100%"=20
            summary=3D"Entrez Links for this Article">
              <TBODY style=3D"FONT-SIZE: 100%">
              <TR style=3D"FONT-SIZE: 100%">
                <TH style=3D"FONT-SIZE: 100%; TEXT-ALIGN: left"=20
                  colSpan=3D2>Medline Plus Health Information</TH></TR>
              <TR style=3D"FONT-SIZE: 100%">
                <TD style=3D"FONT-SIZE: 100%; WHITE-SPACE: nowrap"=20
                  colSpan=3D2><IMG class=3Ddot height=3D9 alt=3D*=20
                  =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/dot.gif"=20
                  width=3D8><A=20
                  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?id=3DMEDPLUS&=
amp;target=3Dhttp%3A%2F%2Fwww.nlm.nih.gov%2Fmedlineplus%2Fcancer.html&amp=
;type=3Dllinks&amp;pmid=3D16809475&amp;link_type=3DENTREZLINKS"=20
                  target=3D_blank>Cancer</A></TD></TR>
              <TR style=3D"FONT-SIZE: 100%">
                <TD style=3D"FONT-SIZE: 100%; WHITE-SPACE: nowrap"=20
                  colSpan=3D2><IMG class=3Ddot height=3D9 alt=3D*=20
                  =
src=3D"http://molinterv.aspetjournals.org/icons/shared/misc/dot.gif"=20
                  width=3D8><A=20
                  =
href=3D"http://molinterv.aspetjournals.org/cgi/external_ref?id=3DMEDPLUS&=
amp;target=3Dhttp%3A%2F%2Fwww.nlm.nih.gov%2Fmedlineplus%2Fstemcells.html&=
amp;type=3Dllinks&amp;pmid=3D16809475&amp;link_type=3DENTREZLINKS"=20
                  target=3D_blank>Stem=20
        =
Cells</A></TD></TR></TBODY></TABLE></TD></TR></TD></TR></TBODY></TABLE></=
TD></TR></TBODY></TABLE><BR=20
clear=3Dall>
<P>
<HR align=3Dleft width=3D450 noShade SIZE=3D1>

<TABLE cellSpacing=3D2 cellPadding=3D2 width=3D450>
  <TBODY>
  <TR>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://molinterv.aspetjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff=20
      size=3D-2>HOME</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://molinterv.aspetjournals.org/help/" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff =
size=3D-2>HELP</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://molinterv.aspetjournals.org/cgi/feedback" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff =
size=3D-2>FEEDBACK</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://molinterv.aspetjournals.org/subscriptions/" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff =
size=3D-2>SUBSCRIPTIONS</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
      style=3D"TEXT-DECORATION: none"=20
      =
href=3D"http://molinterv.aspetjournals.org/contents-by-date.0.shtml"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff=20
      size=3D-2>ARCHIVE</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://molinterv.aspetjournals.org/search.dtl" =
target=3D_top><FONT=20
      face=3Darial,helvetica color=3D#ffffff =
size=3D-2>SEARCH</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
      style=3D"TEXT-DECORATION: none"=20
      href=3D"http://molinterv.aspetjournals.org/content/vol6/issue3/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>TABLE OF=20
      CONTENTS</FONT></A></TD></TR></TBODY></TABLE>
<TABLE cellSpacing=3D2 cellPadding=3D2 width=3D450>
  <TBODY>
  <TR>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://www.aspetjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>ASPET=20
      Journals</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://pharmrev.aspetjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff=20
      size=3D-2>Pharmacological Reviews</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://dmd.aspetjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>Drug=20
      Metabolism and Disposition</FONT></A></TD></TR>
  <TR>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#e1e1e1><FONT=20
      face=3Darial,helvetica color=3D#000000 size=3D-2>Molecular=20
    Interventions</FONT></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://molpharm.aspetjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>Molecular=20
      Pharmacology</FONT></A></TD>
    <TD vAlign=3Dtop noWrap align=3Dmiddle bgColor=3D#003399><A=20
      style=3D"TEXT-DECORATION: none" =
href=3D"http://jpet.aspetjournals.org/"=20
      target=3D_top><FONT face=3Darial,helvetica color=3D#ffffff =
size=3D-2>J=20
      Pharmacology and Exp =
Therapeutics</FONT></A></TD></TR></TBODY></TABLE><FONT=20
face=3Darial,helvetica size=3D-2><A=20
href=3D"http://molinterv.aspetjournals.org/misc/terms.shtml" =
target=3D_top>Copyright=20
=A9 2006 by the American Society for Pharmacology and Experimental=20
Therapeutics.</A></FONT> </BODY></HTML>

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/icons/banner/title.gif
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------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: application/octet-stream
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/adsystem/graphics/1201282056287/molint/990125570.gif?ad=848&adview=true
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------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/icons/spacer.gif

R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAQAICRAEAOw==

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/icons/shared/misc/arrowTtrim.gif

R0lGODlhBAAJAIABAGZmZv///yH5BAEAAAEALAAAAAAEAAkAAAIKjAMHidsLm2HHFAA7

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/icons/shared/toc/free.gif

R0lGODlhIAAHAIABANYTNP///yH5BAEAAAEALAAAAAAgAAcAQAIjjI+pqwDpTAzzVPjQ3Nl2Boah
Q0pkd2YpVq1mW2IypZ5vVQAAOw==

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/icons/shared/misc/dot.gif

R0lGODlhCAAJAIABAAAAAAAAACH5BAEAAAEALAAAAAAIAAkAAAILjI+pCp0Nnlu0hgIAOw==

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/content/vol6/issue3/images/medium/TitleArt_Dean.gif
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------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/icons/toc/rarrow.gif

R0lGODlhCgAVALMAAC5Yqx9MpQo7nevw9ilTqfz9/SlUqe7x+AU3mx1KpQAzmf///wAAAAAAAAAA
AAAAACH5BAAAAAAALAAAAAAKABUAQAQ9cMlJk7oKmSNt3pXGUYuHZcQAjOSytt0lVqecmuhQFMkM
/wFQy+KbmIq4Dyd5EQCSiBQPE9XtiMJJkEWJAAA7

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/icons/toc/uarrow.gif

R0lGODlhCwAJAKIAAN/l8r7L5Qk6nYaezwAzmf///wAAAAAAACH5BAAAAAAALAAAAAALAAkAQAMW
WLrczkEQMl4BLs5NrY1Vo23hyE1DAgA7

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/icons/toc/dot.gif

R0lGODlhCwAJAIAAAP///0JCSiH5BAAAAAAALAAAAAALAAkAQAIMhI+pGb2PWoC0yooKADs=

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/icons/toc/darrow.gif

R0lGODlhCwAJAKIAAN/l8r7L5Qk6nYaezwAzmf///wAAAAAAACH5BAAAAAAALAAAAAALAAkAQAMW
WLrcBS4IQutwWEl6c9tV2IFcJHRKAgA7

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/icons/fig-down.gif

R0lGODlhCAAHAPf/AP///wAAAP//////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
/////////////////////////////////////////////////////ywAAAAACAAHAAAIGQABCBxI
EECAAAUNIhx4sOFChQcLRkxIMCAAOw==

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/content/vol6/issue3/images/small/Fig1_Dean.gif
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------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/icons/fig-up.gif

R0lGODlhCAAHAPf/AP///wAAAP//////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
////////////////////////////////////////////////////////////////////////////
/////////////////////////////////////////////////////ywAAAAACAAHAAAIGAABCBxI
EECAAAUPHhyoUCHBhQkRFiwYEAA7

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/content/vol6/issue3/images/small/Fig2_Dean.gif
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------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/content/vol6/issue3/images/small/Fig3_Dean.gif
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------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/math/gamma.gif

R0lGODlhCQALAOMAAAAAAJ2dnYmJiU1NTRkZGWhoaP///0JCQiwsLAAAAAAAAAAAAAAAAAAAAAAA
AAAAACH5BAEAAAYALAAAAAAJAAsAAAQf0AQCjpEinFKQMAV4XYM4Xtw5pir4tWVrIPIss+p7RQA7

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://molinterv.aspetjournals.org/content/vol6/issue3/images/medium/Dean_Mike.gif
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------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: application/octet-stream
Content-Transfer-Encoding: quoted-printable
Content-Location: http://molinterv.aspetjournals.org/javascript/ajax/xmlhttprequest.js

/*=0A=
=0A=
Cross-Browser XMLHttpRequest v1.2=0A=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=0A=
=0A=
Emulate Gecko 'XMLHttpRequest()' functionality in IE and Opera. Opera =
requires=0A=
the Sun Java Runtime Environment <http://www.java.com/>.=0A=
=0A=
by Andrew Gregory=0A=
http://www.scss.com.au/family/andrew/webdesign/xmlhttprequest/=0A=
=0A=
This work is licensed under the Creative Commons Attribution License. To =
view a=0A=
copy of this license, visit =
http://creativecommons.org/licenses/by-sa/2.5/ or=0A=
send a letter to Creative Commons, 559 Nathan Abbott Way, Stanford, =
California=0A=
94305, USA.=0A=
=0A=
Attribution: Leave my name and web address in this script intact.=0A=
=0A=
Not Supported in Opera=0A=
----------------------=0A=
* user/password authentication=0A=
* responseXML data member=0A=
=0A=
Not Fully Supported in Opera=0A=
----------------------------=0A=
* async requests=0A=
* abort()=0A=
* getAllResponseHeaders(), getAllResponseHeader(header)=0A=
=0A=
*/=0A=
// IE support=0A=
if (window.ActiveXObject && !window.XMLHttpRequest) {=0A=
  window.XMLHttpRequest =3D function() {=0A=
    var msxmls =3D new Array(=0A=
      'Msxml2.XMLHTTP.5.0',=0A=
      'Msxml2.XMLHTTP.4.0',=0A=
      'Msxml2.XMLHTTP.3.0',=0A=
      'Msxml2.XMLHTTP',=0A=
      'Microsoft.XMLHTTP');=0A=
    for (var i =3D 0; i < msxmls.length; i++) {=0A=
      try {=0A=
        return new ActiveXObject(msxmls[i]);=0A=
      } catch (e) {=0A=
      }=0A=
    }=0A=
    return null;=0A=
  };=0A=
}=0A=
// Gecko support=0A=
/* ;-) */=0A=
// Opera support=0A=
if (window.opera && !window.XMLHttpRequest) {=0A=
  window.XMLHttpRequest =3D function() {=0A=
    this.readyState =3D 0; // =
0=3Duninitialized,1=3Dloading,2=3Dloaded,3=3Dinteractive,4=3Dcomplete=0A=
    this.status =3D 0; // HTTP status codes=0A=
    this.statusText =3D '';=0A=
    this._headers =3D [];=0A=
    this._aborted =3D false;=0A=
    this._async =3D true;=0A=
    this._defaultCharset =3D 'ISO-8859-1';=0A=
    this._getCharset =3D function() {=0A=
      var charset =3D _defaultCharset;=0A=
      var contentType =3D =
this.getResponseHeader('Content-type').toUpperCase();=0A=
      val =3D contentType.indexOf('CHARSET=3D');=0A=
      if (val !=3D -1) {=0A=
        charset =3D contentType.substring(val);=0A=
      }=0A=
      val =3D charset.indexOf(';');=0A=
      if (val !=3D -1) {=0A=
        charset =3D charset.substring(0, val);=0A=
      }=0A=
      val =3D charset.indexOf(',');=0A=
      if (val !=3D -1) {=0A=
        charset =3D charset.substring(0, val);=0A=
      }=0A=
      return charset;=0A=
    };=0A=
    this.abort =3D function() {=0A=
      this._aborted =3D true;=0A=
    };=0A=
    this.getAllResponseHeaders =3D function() {=0A=
      return this.getAllResponseHeader('*');=0A=
    };=0A=
    this.getAllResponseHeader =3D function(header) {=0A=
      var ret =3D '';=0A=
      for (var i =3D 0; i < this._headers.length; i++) {=0A=
        if (header =3D=3D '*' || this._headers[i].h =3D=3D header) {=0A=
          ret +=3D this._headers[i].h + ': ' + this._headers[i].v + '\n';=0A=
        }=0A=
      }=0A=
      return ret;=0A=
    };=0A=
    this.getResponseHeader =3D function(header) {=0A=
      var ret =3D getAllResponseHeader(header);=0A=
      var i =3D ret.indexOf('\n');=0A=
      if (i !=3D -1) {=0A=
        ret =3D ret.substring(0, i);=0A=
      }=0A=
      return ret;=0A=
    };=0A=
    this.setRequestHeader =3D function(header, value) {=0A=
      this._headers[this._headers.length] =3D {h:header, v:value};=0A=
    };=0A=
    this.open =3D function(method, url, async, user, password) {=0A=
      this.method =3D method;=0A=
      this.url =3D url;=0A=
      this._async =3D true;=0A=
      this._aborted =3D false;=0A=
      this._headers =3D [];=0A=
      if (arguments.length >=3D 3) {=0A=
        this._async =3D async;=0A=
      }=0A=
      if (arguments.length > 3) {=0A=
        opera.postError('XMLHttpRequest.open() - user/password not =
supported');=0A=
      }=0A=
      this.readyState =3D 1;=0A=
      if (this.onreadystatechange) {=0A=
        this.onreadystatechange();=0A=
      }=0A=
    };=0A=
    this.send =3D function(data) {=0A=
      if (!navigator.javaEnabled()) {=0A=
        alert("XMLHttpRequest.send() - Java must be installed and =
enabled.");=0A=
        return;=0A=
      }=0A=
      if (this._async) {=0A=
        setTimeout(this._sendasync, 0, this, data);=0A=
        // this is not really asynchronous and won't execute until the =
current=0A=
        // execution context ends=0A=
      } else {=0A=
        this._sendsync(data);=0A=
      }=0A=
    }=0A=
    this._sendasync =3D function(req, data) {=0A=
      if (!req._aborted) {=0A=
        req._sendsync(data);=0A=
      }=0A=
    };=0A=
    this._sendsync =3D function(data) {=0A=
      this.readyState =3D 2;=0A=
      if (this.onreadystatechange) {=0A=
        this.onreadystatechange();=0A=
      }=0A=
      // open connection=0A=
      var url =3D new java.net.URL(new =
java.net.URL(window.location.href), this.url);=0A=
      var conn =3D url.openConnection();=0A=
      for (var i =3D 0; i < this._headers.length; i++) {=0A=
        conn.setRequestProperty(this._headers[i].h, this._headers[i].v);=0A=
      }=0A=
      this._headers =3D [];=0A=
      if (this.method =3D=3D 'POST') {=0A=
        // POST data=0A=
        conn.setDoOutput(true);=0A=
        var wr =3D new =
java.io.OutputStreamWriter(conn.getOutputStream(), this._getCharset());=0A=
        wr.write(data);=0A=
        wr.flush();=0A=
        wr.close();=0A=
      }=0A=
      // read response headers=0A=
      // NOTE: the getHeaderField() methods always return nulls for me :(=0A=
      var gotContentEncoding =3D false;=0A=
      var gotContentLength =3D false;=0A=
      var gotContentType =3D false;=0A=
      var gotDate =3D false;=0A=
      var gotExpiration =3D false;=0A=
      var gotLastModified =3D false;=0A=
      for (var i =3D 0; ; i++) {=0A=
        var hdrName =3D conn.getHeaderFieldKey(i);=0A=
        var hdrValue =3D conn.getHeaderField(i);=0A=
        if (hdrName =3D=3D null && hdrValue =3D=3D null) {=0A=
          break;=0A=
        }=0A=
        if (hdrName !=3D null) {=0A=
          this._headers[this._headers.length] =3D {h:hdrName, =
v:hdrValue};=0A=
          switch (hdrName.toLowerCase()) {=0A=
            case 'content-encoding': gotContentEncoding =3D true; break;=0A=
            case 'content-length'  : gotContentLength   =3D true; break;=0A=
            case 'content-type'    : gotContentType     =3D true; break;=0A=
            case 'date'            : gotDate            =3D true; break;=0A=
            case 'expires'         : gotExpiration      =3D true; break;=0A=
            case 'last-modified'   : gotLastModified    =3D true; break;=0A=
          }=0A=
        }=0A=
      }=0A=
      // try to fill in any missing header information=0A=
      var val;=0A=
      val =3D conn.getContentEncoding();=0A=
      if (val !=3D null && !gotContentEncoding) =
this._headers[this._headers.length] =3D {h:'Content-encoding', v:val};=0A=
      val =3D conn.getContentLength();=0A=
      if (val !=3D -1 && !gotContentLength) =
this._headers[this._headers.length] =3D {h:'Content-length', v:val};=0A=
      val =3D conn.getContentType();=0A=
      if (val !=3D null && !gotContentType) =
this._headers[this._headers.length] =3D {h:'Content-type', v:val};=0A=
      val =3D conn.getDate();=0A=
      if (val !=3D 0 && !gotDate) this._headers[this._headers.length] =
=3D {h:'Date', v:(new Date(val)).toUTCString()};=0A=
      val =3D conn.getExpiration();=0A=
      if (val !=3D 0 && !gotExpiration) =
this._headers[this._headers.length] =3D {h:'Expires', v:(new =
Date(val)).toUTCString()};=0A=
      val =3D conn.getLastModified();=0A=
      if (val !=3D 0 && !gotLastModified) =
this._headers[this._headers.length] =3D {h:'Last-modified', v:(new =
Date(val)).toUTCString()};=0A=
      // read response data=0A=
      var reqdata =3D '';=0A=
      var stream =3D conn.getInputStream();=0A=
      if (stream) {=0A=
        var reader =3D new java.io.BufferedReader(new =
java.io.InputStreamReader(stream, this._getCharset()));=0A=
        var line;=0A=
        while ((line =3D reader.readLine()) !=3D null) {=0A=
          if (this.readyState =3D=3D 2) {=0A=
            this.readyState =3D 3;=0A=
            if (this.onreadystatechange) {=0A=
              this.onreadystatechange();=0A=
            }=0A=
          }=0A=
          reqdata +=3D line + '\n';=0A=
        }=0A=
        reader.close();=0A=
        this.status =3D 200;=0A=
        this.statusText =3D 'OK';=0A=
        this.responseText =3D reqdata;=0A=
        this.readyState =3D 4;=0A=
        if (this.onreadystatechange) {=0A=
          this.onreadystatechange();=0A=
        }=0A=
        if (this.onload) {=0A=
          this.onload();=0A=
        }=0A=
      } else {=0A=
        // error=0A=
        this.status =3D 404;=0A=
        this.statusText =3D 'Not Found';=0A=
        this.responseText =3D '';=0A=
        this.readyState =3D 4;=0A=
        if (this.onreadystatechange) {=0A=
          this.onreadystatechange();=0A=
        }=0A=
        if (this.onerror) {=0A=
          this.onerror();=0A=
        }=0A=
      }=0A=
    };=0A=
  };=0A=
}=0A=
// ActiveXObject emulation=0A=
if (!window.ActiveXObject && window.XMLHttpRequest) {=0A=
  window.ActiveXObject =3D function(type) {=0A=
    switch (type.toLowerCase()) {=0A=
      case 'microsoft.xmlhttp':=0A=
      case 'msxml2.xmlhttp':=0A=
      case 'msxml2.xmlhttp.3.0':=0A=
      case 'msxml2.xmlhttp.4.0':=0A=
      case 'msxml2.xmlhttp.5.0':=0A=
        return new XMLHttpRequest();=0A=
    }=0A=
    return null;=0A=
  };=0A=
}=0A=

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: application/octet-stream
Content-Transfer-Encoding: quoted-printable
Content-Location: http://molinterv.aspetjournals.org/javascript/ajax/utility.js

/************************************************************************=
*****=0A=
 * javascript/ajax/utility.js=0A=
 *=0A=
 * Utility functions for working with XMLHttpRequest data.=0A=
 *=0A=
 * Copyright 2006 Board of Trustees of the Leland Stanford Junior =
University.=0A=
 =
*************************************************************************=
***/=0A=
=0A=
/*=0A=
 * Copy XML nodes into an HTMLElement. This effectively=0A=
 * clones XML markup which uses XHTML naming conventions=0A=
 * into an HTML DOM.=0A=
 */=0A=
function copy_xml_to_html(src, dst) {=0A=
  if (src.nodeType =3D=3D 1) { /* Node.ELEMENT_NODE */=0A=
    var e =3D document.createElement(src.nodeName);=0A=
    for (var i =3D 0; i < src.childNodes.length; i++) {=0A=
	  copy_xml_to_html(src.childNodes[i], e);=0A=
    }=0A=
    for (var i =3D 0; i < src.attributes.length; i++) {=0A=
      var n =3D src.attributes[i].name;=0A=
      var v =3D unescape_xml_string(src.attributes[i].value);      =0A=
      e.setAttribute(n, v);=0A=
      if (n =3D=3D "class") {=0A=
        e.className =3D v;=0A=
      }=0A=
      else if (n =3D=3D "style") {=0A=
        set_css_style(v, e, "");=0A=
      }=0A=
    }=0A=
    dst.appendChild(e);=0A=
  }=0A=
  else if (src.nodeType =3D=3D 3) { /* Node.TEXT_NODE */=0A=
    dst.appendChild(document.createTextNode(src.nodeValue));=0A=
  }=0A=
}=0A=
=0A=
/* =0A=
 * It is unclear that this is the right thing to be calling=0A=
 * from copy_xml_to_html, but it appears that Safari decides=0A=
 * to convert &amp; to the NCR &#35;, and then encodes that=0A=
 * NCR to &%26%2338;.  So, I'm going to treat the DOM Attr=0A=
 * value as a plain string, and run our XML string input=0A=
 * through the decoding routine below.=0A=
 */=0A=
function unescape_xml_string(s) {=0A=
  return s.replace(/&apos;/g, "'")=0A=
          .replace(/&#39;/g,  "'")=0A=
          .replace(/&quot;/g, "\"")=0A=
          .replace(/&#34;/g,  "\"")=0A=
          .replace(/&gt;/g,   ">")=0A=
          .replace(/&#62;/g,  ">")=0A=
          .replace(/&lt;/g,   "<")=0A=
          .replace(/&#60;/g,  "<")=0A=
          .replace(/&amp;/g,  "&")=0A=
          .replace(/&#38;/g,  "&");=0A=
}=0A=
=0A=
/*=0A=
 * Parse set of CSS rules and apply them to an element.=0A=
 * This is quite horrifying, but I'm unable to determine=0A=
 * how else to handle this with IE 6.  FireFox and other=0A=
 * sane browsers let you simply set the style attribute=0A=
 * or use e.style.setProperty(rule, value, priority),=0A=
 * IE 6 appears to have neither of these capabilities..=0A=
 */=0A=
function set_css_style(css, e, priority) {=0A=
  var rules =3D css.split(";");=0A=
  for (var i =3D 0; i < rules.length; i++) {=0A=
    var nvpair =3D rules[i].split(":");=0A=
    if (nvpair.length =3D=3D 2) {=0A=
      try {=0A=
        var name  =3D nvpair[0]; /* style attribute */=0A=
        var value =3D nvpair[1]; /* attribute value */=0A=
  =0A=
        /*=0A=
         * For each possible style attribute, set the=0A=
         * appropriate style property in the element.=0A=
         */=0A=
        if (name =3D=3D "background") {=0A=
           e.style.background =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-attachment") {=0A=
          e.style.backgroundAttachment =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-color") {=0A=
          e.style.backgroundColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-image") {=0A=
          e.style.backgroundImage =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-position") {=0A=
          e.style.backgroundPosition =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-position-x") {=0A=
          e.style.backgroundPositionX =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-position-y") {=0A=
          e.style.backgroundPositionY =3D value;=0A=
        }=0A=
        else if (name =3D=3D "background-repeat") {=0A=
          e.style.backgroundRepeat =3D value;=0A=
        }=0A=
        else if (name =3D=3D "behavior") {=0A=
          e.style.behavior =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border") {=0A=
          e.style.border =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-bottom") {=0A=
          e.style.borderBottom =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-bottom-color") {=0A=
          e.style.borderBottomColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-bottom-style") {=0A=
          e.style.borderBottomStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-bottom-width") {=0A=
          e.style.borderBottomWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-collapse") {=0A=
          e.style.borderCollapse =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-color") {=0A=
          e.style.borderColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-left") {=0A=
          e.style.borderLeft =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-left-color") {=0A=
          e.style.borderLeftColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-left-style") {=0A=
          e.style.borderLeftStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-left-width") {=0A=
          e.style.borderLeftWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-right") {=0A=
          e.style.borderRight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-right-color") {=0A=
          e.style.borderRightColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-right-style") {=0A=
          e.style.borderRightStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-right-width") {=0A=
          e.style.borderRightWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-style") {=0A=
          e.style.borderStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-top") {=0A=
          e.style.borderTop =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-top-color") {=0A=
          e.style.borderTopColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-top-style") {=0A=
          e.style.borderTopStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-top-width") {=0A=
          e.style.borderTopWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "border-width") {=0A=
          e.style.borderWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "bottom") {=0A=
          e.style.bottom =3D value;=0A=
        }=0A=
        else if (name =3D=3D "clear") {=0A=
          e.style.clear =3D value;=0A=
        }=0A=
        else if (name =3D=3D "clip") {=0A=
          e.style.clip =3D value;=0A=
        }=0A=
        else if (name =3D=3D "color") {=0A=
          e.style.color =3D value;=0A=
        }=0A=
        else if (name =3D=3D "cssText") {=0A=
          e.style.Sets =3D value;=0A=
        }=0A=
        else if (name =3D=3D "cursor") {=0A=
          e.style.cursor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "direction") {=0A=
          e.style.direction =3D value;=0A=
        }=0A=
        else if (name =3D=3D "display") {=0A=
          e.style.display =3D value;=0A=
        }=0A=
        else if (name =3D=3D "font") {=0A=
          e.style.font =3D value;=0A=
        }=0A=
        else if (name =3D=3D "font-family") {=0A=
          e.style.fontFamily =3D value;=0A=
        }=0A=
        else if (name =3D=3D "font-size") {=0A=
          e.style.fontSize =3D value;=0A=
        }=0A=
        else if (name =3D=3D "font-style") {=0A=
          e.style.fontStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "font-variant") {=0A=
          e.style.fontVariant =3D value;=0A=
        }=0A=
        else if (name =3D=3D "font-weight") {=0A=
          e.style.fontWeight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "height") {=0A=
          e.style.height =3D value;=0A=
        }=0A=
        else if (name =3D=3D "ime-mode") {=0A=
          e.style.imeMode =3D value;=0A=
        }=0A=
        else if (name =3D=3D "layout-flow") {=0A=
          e.style.layoutFlow =3D value;=0A=
        }=0A=
        else if (name =3D=3D "layout-grid") {=0A=
          e.style.layoutGrid =3D value;=0A=
        }=0A=
        else if (name =3D=3D "layout-grid-char") {=0A=
          e.style.layoutGridChar =3D value;=0A=
        }=0A=
        else if (name =3D=3D "layout-grid-line") {=0A=
          e.style.layoutGridLine =3D value;=0A=
        }=0A=
        else if (name =3D=3D "layout-grid-mode") {=0A=
          e.style.layoutGridMode =3D value;=0A=
        }=0A=
        else if (name =3D=3D "layout-grid-type") {=0A=
          e.style.layoutGridType =3D value;=0A=
        }=0A=
        else if (name =3D=3D "left") {=0A=
          e.style.left =3D value;=0A=
        }=0A=
        else if (name =3D=3D "letter-spacing") {=0A=
          e.style.letterSpacing =3D value;=0A=
        }=0A=
        else if (name =3D=3D "line-break") {=0A=
          e.style.lineBreak =3D value;=0A=
        }=0A=
        else if (name =3D=3D "line-height") {=0A=
          e.style.lineHeight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "list-style") {=0A=
          e.style.listStyle =3D value;=0A=
        }=0A=
        else if (name =3D=3D "list-style-image") {=0A=
          e.style.listStyleImage =3D value;=0A=
        }=0A=
        else if (name =3D=3D "list-style-position") {=0A=
          e.style.listStylePosition =3D value;=0A=
        }=0A=
        else if (name =3D=3D "list-style-type") {=0A=
          e.style.listStyleType =3D value;=0A=
        }=0A=
        else if (name =3D=3D "margin") {=0A=
          e.style.margin =3D value;=0A=
        }=0A=
        else if (name =3D=3D "margin-bottom") {=0A=
          e.style.marginBottom =3D value;=0A=
        }=0A=
        else if (name =3D=3D "margin-left") {=0A=
          e.style.marginLeft =3D value;=0A=
        }=0A=
        else if (name =3D=3D "margin-right") {=0A=
          e.style.marginRight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "margin-top") {=0A=
          e.style.marginTop =3D value;=0A=
        }=0A=
        else if (name =3D=3D "min-height") {=0A=
          e.style.minHeight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "overflow") {=0A=
          e.style.overflow =3D value;=0A=
        }=0A=
        else if (name =3D=3D "overflow-x") {=0A=
          e.style.overflowX =3D value;=0A=
        }=0A=
        else if (name =3D=3D "overflow-y") {=0A=
          e.style.overflowY =3D value;=0A=
        }=0A=
        else if (name =3D=3D "padding") {=0A=
          e.style.padding =3D value;=0A=
        }=0A=
        else if (name =3D=3D "padding-bottom") {=0A=
          e.style.paddingBottom =3D value;=0A=
        }=0A=
        else if (name =3D=3D "padding-left") {=0A=
          e.style.paddingLeft =3D value;=0A=
        }=0A=
        else if (name =3D=3D "padding-right") {=0A=
          e.style.paddingRight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "padding-top") {=0A=
          e.style.paddingTop =3D value;=0A=
        }=0A=
        else if (name =3D=3D "page-break-after") {=0A=
          e.style.pageBreakAfter =3D value;=0A=
        }=0A=
        else if (name =3D=3D "page-break-before") {=0A=
          e.style.pageBreakBefore =3D value;=0A=
        }=0A=
        else if (name =3D=3D "pixelBottom") {=0A=
          e.style.pixelBottom =3D value;=0A=
        }=0A=
        else if (name =3D=3D "pixelHeight") {=0A=
          e.style.pixelHeight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "pixelLeft") {=0A=
          e.style.pixelLeft =3D value;=0A=
        }=0A=
        else if (name =3D=3D "pixelRight") {=0A=
          e.style.pixelRight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "pixelTop") {=0A=
          e.style.pixelTop =3D value;=0A=
        }=0A=
        else if (name =3D=3D "pixelWidth") {=0A=
          e.style.pixelWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "posBottom") {=0A=
          e.style.posBottom =3D value;=0A=
        }=0A=
        else if (name =3D=3D "posHeight") {=0A=
          e.style.posHeight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "position") {=0A=
          e.style.position =3D value;=0A=
        }=0A=
        else if (name =3D=3D "posLeft") {=0A=
          e.style.posLeft =3D value;=0A=
        }=0A=
        else if (name =3D=3D "posRight") {=0A=
          e.style.posRight =3D value;=0A=
        }=0A=
        else if (name =3D=3D "posTop") {=0A=
          e.style.posTop =3D value;=0A=
        }=0A=
        else if (name =3D=3D "posWidth") {=0A=
          e.style.posWidth =3D value;=0A=
        }=0A=
        else if (name =3D=3D "right") {=0A=
          e.style.right =3D value;=0A=
        }=0A=
        else if (name =3D=3D "ruby-align") {=0A=
          e.style.rubyAlign =3D value;=0A=
        }=0A=
        else if (name =3D=3D "ruby-overhang") {=0A=
          e.style.rubyOverhang =3D value;=0A=
        }=0A=
        else if (name =3D=3D "ruby-position") {=0A=
          e.style.rubyPosition =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-3dlight-color") {=0A=
          e.style.scrollbar3dLightColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-arrow-color") {=0A=
          e.style.scrollbarArrowColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-base-color") {=0A=
          e.style.scrollbarBaseColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-darkshadow-color") {=0A=
          e.style.scrollbarDarkShadowColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-face-color") {=0A=
          e.style.scrollbarFaceColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-highlight-color") {=0A=
          e.style.scrollbarHighlightColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-shadow-color") {=0A=
          e.style.scrollbarShadowColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "scrollbar-track-color") {=0A=
          e.style.scrollbarTrackColor =3D value;=0A=
        }=0A=
        else if (name =3D=3D "float") {=0A=
          e.style.styleFloat =3D value;=0A=
        }=0A=
        else if (name =3D=3D "table-layout") {=0A=
          e.style.tableLayout =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-align") {=0A=
          e.style.textAlign =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-align-last") {=0A=
          e.style.textAlignLast =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-autospace") {=0A=
          e.style.textAutospace =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-decoration") {=0A=
          e.style.textDecoration =3D value;=0A=
        }=0A=
        else if (name =3D=3D "textDecorationBlink") {=0A=
          e.style.textDecorationBlink =3D value;=0A=
        }=0A=
        else if (name =3D=3D "textDecorationLineThrough") {=0A=
          e.style.textDecorationLineThrough =3D value;=0A=
        }=0A=
        else if (name =3D=3D "textDecorationNone") {=0A=
          e.style.textDecorationNone =3D value;=0A=
        }=0A=
        else if (name =3D=3D "textDecorationOverline") {=0A=
          e.style.textDecorationOverline =3D value;=0A=
        }=0A=
        else if (name =3D=3D "textDecorationUnderline") {=0A=
          e.style.textDecorationUnderline =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-indent") {=0A=
          e.style.textIndent =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-justify") {=0A=
          e.style.textJustify =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-kashida-space") {=0A=
          e.style.textKashidaSpace =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-overflow") {=0A=
          e.style.textOverflow =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-transform") {=0A=
          e.style.textTransform =3D value;=0A=
        }=0A=
        else if (name =3D=3D "text-underline-position") {=0A=
          e.style.textUnderlinePosition =3D value;=0A=
        }=0A=
        else if (name =3D=3D "top") {=0A=
          e.style.top =3D value;=0A=
        }=0A=
        else if (name =3D=3D "unicode-bidi") {=0A=
          e.style.unicodeBidi =3D value;=0A=
        }=0A=
        else if (name =3D=3D "vertical-align") {=0A=
          e.style.verticalAlign =3D value;=0A=
        }=0A=
        else if (name =3D=3D "visibility") {=0A=
          e.style.visibility =3D value;=0A=
        }=0A=
        else if (name =3D=3D "white-space") {=0A=
          e.style.whiteSpace =3D value;=0A=
        }=0A=
        else if (name =3D=3D "width") {=0A=
          e.style.width =3D value;=0A=
        }=0A=
        else if (name =3D=3D "word-break") {=0A=
          e.style.wordBreak =3D value;=0A=
        }=0A=
        else if (name =3D=3D "word-spacing") {=0A=
          e.style.wordSpacing =3D value;=0A=
        }=0A=
        else if (name =3D=3D "word-wrap") {=0A=
          e.style.wordWrap =3D value;=0A=
        }=0A=
        else if (name =3D=3D "writing-mode") {=0A=
          e.style.writingMode =3D value;=0A=
        }=0A=
        else if (name =3D=3D "z-index") {=0A=
          e.style.zIndex =3D value;=0A=
        }=0A=
        else if (name =3D=3D "zoom") {=0A=
          e.style.zoom =3D value;=0A=
        }=0A=
      }=0A=
      catch (e) {=0A=
        /* ignore error on attempt to set e.style.[property] */=0A=
      }=0A=
    }=0A=
  }=0A=
}=0A=

------=_NextPart_000_0000_01C85F7F.F9B604C0
Content-Type: application/octet-stream
Content-Transfer-Encoding: quoted-printable
Content-Location: http://molinterv.aspetjournals.org/javascript/entrez/callback.js

/************************************************************************=
*****=0A=
 * javascript/entrez/callback.js=0A=
 *=0A=
 * Entrez Linking callback to populate content box.=0A=
 *=0A=
 * Copyright 2006 Board of Trustees of the Leland Stanford Junior =
University.=0A=
 =
*************************************************************************=
***/=0A=
=0A=
/*=0A=
 * Execute callback to fill content box with Entrez Linking information.=0A=
 */=0A=
function entrez_callback(pmid, callback_url) {=0A=
  /*=0A=
   * MSIE 5.5 and below have issues with the JavaScript=0A=
   * used for Entrez Linking. For now we have to disable=0A=
   * the callback until we can track down a proper fix=0A=
   * (or everybody sanely upgrades to version 6 or 7!).=0A=
   */=0A=
  if (navigator) {=0A=
    var appname =3D navigator.appName;=0A=
    if (appname =3D=3D "Microsoft Internet Explorer") {=0A=
      var userAgent =3D navigator["userAgent"];=0A=
      var s =3D "MSIE ";=0A=
      var n =3D -1;      =0A=
      if ((n =3D userAgent.indexOf(s)) !=3D -1) {=0A=
        var v =3D parseFloat(userAgent.substring(n+s.length));=0A=
        if (v < 6) {=0A=
          return;=0A=
        }=0A=
      }=0A=
    }=0A=
  }=0A=
=0A=
  /*=0A=
   * Acquire table row element to update, initiate callback=0A=
   * to update table with Entrez Links.=0A=
   */=0A=
  var tr =3D document.getElementById('entrez_callback_'+pmid);=0A=
  if (!tr) {=0A=
    return;=0A=
  }=0A=
  var req =3D new XMLHttpRequest();=0A=
  if (!req) {=0A=
    return;=0A=
  }=0A=
  req.onreadystatechange =3D function() {=0A=
    if (req.readyState =3D=3D 4 && (req.status =3D=3D 200 || req.status =
=3D=3D 304)) {=0A=
      var src =3D req.responseXML.documentElement;=0A=
      var dst =3D document.createDocumentFragment();=0A=
      for (var i =3D 0; i < src.childNodes.length; i++) {=0A=
      	copy_xml_to_html(src.childNodes[i], dst);=0A=
      }=0A=
      var tbl =3D tr.parentNode;=0A=
      tbl.replaceChild(dst, tr);=0A=
    }=0A=
  }=0A=
  req.open('GET', callback_url, true);=0A=
  req.send(null);=0A=
}=0A=

------=_NextPart_000_0000_01C85F7F.F9B604C0--
